EP2066406A2 - Kosmetische zubereitungen auf basis molekular geprägter polymere - Google Patents

Kosmetische zubereitungen auf basis molekular geprägter polymere

Info

Publication number
EP2066406A2
EP2066406A2 EP07803486A EP07803486A EP2066406A2 EP 2066406 A2 EP2066406 A2 EP 2066406A2 EP 07803486 A EP07803486 A EP 07803486A EP 07803486 A EP07803486 A EP 07803486A EP 2066406 A2 EP2066406 A2 EP 2066406A2
Authority
EP
European Patent Office
Prior art keywords
acid
oil
meth
polymer
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07803486A
Other languages
German (de)
English (en)
French (fr)
Inventor
Volker Wendel
Oliver BRÜGGEMANN
Arne Ptock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to EP07803486A priority Critical patent/EP2066406A2/de
Publication of EP2066406A2 publication Critical patent/EP2066406A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8194—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties

Definitions

  • the present invention relates to cosmetic or dermatological preparations containing at least one active ingredient, at least one in the presence of this active molecularly imprinted polymer and at least one fatty phase.
  • thermolabile, oxidation-sensitive or volatile cosmetic or dermatological agents it is desirable to protect them within the formulation.
  • controlled release the prolonged release of cosmetic or dermatological active substances, the so-called controlled release.
  • polymeric microencapsulations for example, have proved to be useful for some applications, which in addition can protect the active ingredients.
  • the active ingredients should not be released during storage of the preparation but only at the intended site of action.
  • the object of the present invention was to provide formulations with selective affinity for a particular active ingredient, from which this active ingredient is released gradually and gently only at the site of action. Furthermore, it was an object of the present invention to provide preparations from which the release of an active substance is stimulated by physiological influences, such as, for example, by contact with skin or other organs. In other words, an object of the present invention was to enable a targeted release of an active ingredient of a preparation, wherein the buffer capacity of the skin or the body as a selective Noxe after application of the preparation to release the active ingredient is sufficient.
  • cosmetic or dermatological preparations containing at least one active substance, at least one polymer which is molecularly embossed in the presence of this active substance and at least one fatty phase.
  • Preparations according to the invention enable a targeted release of hydrophilic, amphiphilic, lipophilic, oxidation-sensitive or hydrolysis-sensitive active substances. This applies to all customary cosmetic and dermatological applications and dosage forms.
  • cosmetic active ingredients are described explicitly and the dermatological equivalents are not expressly mentioned, at least dermatological active substances, preparations, acceptance and uses are also included.
  • molecular imprinting has been a technology that has been intensively studied for several years, above all in the fields of chromatography, solid phase extraction and wastewater treatment.
  • HPLC high pressure liquid chromatography
  • Kanekiyo et al. (Angew Chem .. Int, Ed., 2003, 42, 3014-16) describe molecularly imprinted polymers (MIPs) whose affinity for the guest molecules that were imprinted with is pH-dependent.
  • MIPs molecularly imprinted polymers
  • the MIP used was a polymer crosslinked with N, N-methylenebisacrylamide and based on acryloyl-amylose and carboxyl group-containing monomers.
  • As a guest molecule bisphenol-A was used. It has been demonstrated that for these COG-containing MIPs, the binding ability for bisphenol A decreases with increasing pH.
  • EP-A 925776 describes molecularly imprinted polymers with binding sites for at least one organoleptic substance. Cosmetic preparations which also contain a fatty phase are not described.
  • At least one active ingredient means that one, two or more of the following named cosmetic active ingredients can be used for the preparation of the molecularly imprinted polymer, preferably one or two, particularly preferably one.
  • the molecularly imprinted polymers comprise a) at least one compound having a free-radically polymerizable double bond and b) at least one compound having at least two unconjugated free-radically polymerizable double bonds.
  • compound a) is preferably selected from a1) anionic or anionic, radically polymerizable compounds a2) esters of ⁇ , ß-ethylenically unsaturated carboxylic acids a3) amides of ⁇ , ß-ethylenically unsaturated carboxylic acids a4) esters of vinyl alcohol or allyl alcohol with Ci-C3o Monocarboxylic acids, vinyl ethers, vinyllactams, vinylimidazoles, vinylaromatics, vinyl halides, vinylidene halides, vinylpyridines, C 2 -C 8 monoolefins, nonaromatic hydrocarbons having at least 2 conjugated double bonds and a5) mixtures thereof.
  • the anionic or anionogenic, free-radically polymerizable compounds a1) include monoethylenically unsaturated mono- and dicarboxylic acids having 3 to 25, preferably 3 to 6, carbon atoms, which can also be used in the form of their salts or anhydrides. Examples thereof are acrylic acid, methacrylic acid, ethacrylic acid, .alpha.-chloroacrylic acid, crotonic acid, maleic acid, maleic anhydride, itaconic acid, citraconic acid, mesaconic acid, glutaconic acid, aconitic acid and fumaric acid.
  • the compounds a1) furthermore include the half-esters of monoethylenically unsaturated dicarboxylic acids having 4 to 10, preferably 4 to 6, carbon atoms, e.g. of maleic acid, such as monomethyl maleate.
  • the compounds a1) also include monoethylenically unsaturated sulfonic acids and phosphonic acids, for example vinylsulfonic acid, allylsulfonic acid, sulfoethyl acrylate, sulfoethyl methacrylate, sulfopropyl acrylate, sulfopropyl methacrylate, 2-hydroxy-3-acryloxypropylsulfonic acid, 2-hydroxy-3-methacryloxypropylsulfonic acid, styrenesulfonic acid, 2-acrylamido 2-methylpropanesulfonic acid, vinylphosphonic acid and allylphosphonic acid.
  • monoethylenically unsaturated sulfonic acids and phosphonic acids for example vinylsulfonic acid, allylsulfonic acid, sulfoethyl acrylate, sulfoethyl methacrylate, sulfopropyl acrylate, sulfo
  • the compounds a1) also include the salts of the abovementioned acids, in particular the sodium, potassium and ammonium salts, and the salts with the cosmetically acceptable amines.
  • the compounds a1) can be used as such or as mixtures with one another.
  • the compound a1) is preferably selected from acrylic acid, methacrylic acid, ethacrylic acid, ⁇ -chloroacrylic acid, crotonic acid, maleic acid, maleic anhydride, fumaric acid, itaconic acid, citraconic acid, mesaconic acid, glutaconic acid, aconitic acid and mixtures thereof, particularly preferably acrylic acid, methacrylic acid, mixtures thereof and in particular methacrylic acid ,
  • Compound a2) is for example selected from the group consisting of methyl (meth) acrylate, ethyl (meth) acrylate, n-propyl (meth) acrylate, i-propyl (meth) acrylate, n-butyl (meth) acrylate, tert Butyl (meth) acrylate, isobutyl (meth) acrylate, sec-butyl (meth) acrylate, 2-pentyl (meth) acrylate, 3-pentyl (meth) acrylate, isopentyl (meth) acrylate, Neopentyl (neth) acrylate, n-octyl (meth) acrylate, 1,1,3,3-tetramethylbutyl (meth) acrylate, ethylhexyl (meth) acrylate, n-nonyl (meth) acrylate, n-decyl (meth) acrylate
  • Compound a2) is preferably selected from the esters of (meth) acrylic acid.
  • Compound a2) is particularly preferably selected from methacrylates and acrylates.
  • Preferred (meth) acrylates are C 1 -C 10 -alkyl (meth) acrylates and in particular the abovementioned C 1 -C 4 -alkyl (meth) acrylates.
  • Suitable compounds a2) are also the esters of ⁇ , ß-ethylenically unsaturated mono- and dicarboxylic acids with amino alcohols.
  • Preferred amino alcohols are C 2 -C 2 -aminoalcohols which are mono- or -dialkylated on the amino nitrogen C 1 -C 8 .
  • esters As the acid component of these esters are z. Acrylic acid, methacrylic acid, fumaric acid, maleic acid, itaconic acid, crotonic acid, maleic anhydride, monobutyl maleate and mixtures thereof.
  • the acid component used is preferably acrylic acid, methacrylic acid and mixtures thereof.
  • Preferred monomers a3) are N-tert-butylaminoethyl (meth) acrylate, N, N-dimethylaminomethyl (meth) acrylate, N, N-dimethylaminoethyl (meth) acrylate, N, N-diethylaminoethyl (meth) acrylate, N, N- Dimethylaminopropyl (meth) acrylate, N, N-diethylaminopropyl (meth) acrylate and N, N-dimethylaminocyclohexyl (meth) acrylate.
  • Particularly preferred are N-tert-butylaminoethyl (meth) acrylate and N, N-dimethylaminoethyl (meth) acrylate.
  • Suitable compounds a3) are also esters of ⁇ , ⁇ -ethylenically unsaturated mono- and dicarboxylic acids with diols, for example 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate,
  • the compounds a3) may preferably be selected from the group consisting of acrylamide, methacrylamide, N-methyl (meth) acrylamide, N-ethyl (meth) acrylamide, N-propyl (meth) acrylamide, N- (n-butyl) (meth ) acrylamide, N- (tert-butyl) (meth) acrylamide, N, N-dimethyl (meth) acrylamide, N, N-diethyl (meth) acrylamide, piperidinyl (meth) acrylamide and morpholinyl (meth) acrylamide, N- (n-octyl) (meth) acrylamide, N- (1,1,3,3-tetramethylbutyl) (meth) acrylamide, N-ethylhexyl (meth) acrylamide, N- (n-nonyl) (meth) acrylamide, N- (n-decyl) (meth) acrylamide, N
  • Suitable monomers a3) are also the amides of the abovementioned ⁇ , ⁇ -ethylenically unsaturated mono- and dicarboxylic acids with diamines which have at least one primary or secondary amino group. Preferred are diamines having a tertiary and a primary or secondary amino group. Suitable as monomers a3) are z.
  • Suitable monomers a3) are also the hydroxyalkylamides of the abovementioned ⁇ , ⁇ -ethylenically unsaturated mono- and dicarboxylic acids, such as, for example, 2-hydroxyethylacrylamide, 2-hydroxyethylmethacrylamide, 2-hydroxyethylethacrylamide, 2-hydroxypropylacrylamide, 2-hydroxypropylmethacrylamide, 3-hydroxypropylacrylamide, 3-hydroxypropylmethacrylamide , 3-hydroxybutylacrylamide, 3-hydroxybutylmethacrylamide, 4-hydroxybutylacrylamide, 4-hydroxybutylmethacrylamide, 6-hydroxyhexylacrylamide, 6-hydroxyhexylmethacrylamide, 3-hydroxy-2-ethylhexylacrylamide and 3-hydroxy-2-ethylhexylmethacrylamide.
  • Suitable compounds a4) are, for example, N-vinyllactams and derivatives thereof which, for. B. one or more Ci-C 6 alkyl substituents, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, etc. may have. These include z.
  • N-vinylpyrrolidone N-vinylpiperidone, N-vinylcaprolactam
  • N-vinyl-5-methyl-2-pyrrolidone N-vinyl-5-ethyl-2-pyrrolidone
  • N-vinyl-6-methyl-2-piperidone N-vinyl-6-ethyl-2-piperidone
  • N-vinyl-7-methyl-2-caprolactam N-vinyl-7-ethyl-2-caprolactam.
  • Particular preference is given to using N-vinylpyrrolidone and / or N-vinylcaprolactam.
  • Suitable compounds a4) are, for example, also N-vinylimidazole compounds of the general formula (II)
  • R 5 to R 7 independently of one another represent hydrogen, C 1 -C 4 -alkyl or phenyl.
  • Compounds b) are compounds having at least two non-conjugated free-radically polymerizable double bonds. These compounds b) are usually and hereinafter also referred to as crosslinkers.
  • Suitable compounds b) are, for example, acrylic esters, methacrylic esters, allyl ethers or vinyl ethers of at least dihydric alcohols.
  • the OH groups of the underlying alcohols may be completely or partially etherified or esterified; however, the crosslinkers contain at least two ethylenically unsaturated groups.
  • Examples of the underlying alcohols are dihydric alcohols such as 1, 2-ethanediol, 1, 2-propanediol, 1, 3-propanediol, 1, 2-butanediol, 1, 3-butanediol, 2,3-butanediol, 1, 4-butanediol , But-2-ene-1, 4-diol, 1, 2-pentanediol, 1, 5-pentanediol,
  • ethylene oxide or propylene oxide Apart from the homopolymers of ethylene oxide or propylene oxide, it is also possible to use block copolymers of ethylene oxide or propylene oxide or copolymers which contain incorporated ethylene oxide and propylene oxide groups.
  • underlying alcohols having more than two OH groups are trimethylolpropane, glycerol, pentaerythritol, 1, 2,5-pentanetriol, 1, 2,6-hexanetriol, triethoxycyanuric acid, sorbitan, sugars such as sucrose, glucose, mannose.
  • the polyhydric alcohols can also be used after reaction with ethylene oxide or propylene oxide as the corresponding ethoxylates or propoxylates.
  • the polyhydric alcohols can also be first converted by reaction with epichlorohydrin in the corresponding glycidyl ether. Preference is given to ethylene glycol di (meth) acrylate and polyethylene glycol di (meth) acrylates.
  • Further suitable compounds b) are the vinyl esters or the esters of monohydric, unsaturated alcohols with ethylenically unsaturated C 3 -C 6 -carboxylic acids, for example acrylic acid, methacrylic acid, itaconic acid, maleic acid or fumaric acid.
  • examples of such alcohols are allyl alcohol, 1-buten-3-ol, 5-hexene-1-ol, 1-octen-3-ol, 9-decen-1-ol, dicyclopentenyl alcohol, 10-undecene-1-ol, cinnamyl alcohol Citronellol, crotyl alcohol or cis-9-octadecene-1-ol.
  • you can also the monohydric, unsaturated alcohols with polybasic carboxylic acids for example malonic acid, tartaric acid, trimellitic acid, phthalic acid, terephthalic acid, citric acid or succinic acid.
  • suitable compounds b) are esters of unsaturated carboxylic acids with the polyhydric alcohols described above, for example oleic acid, crotonic acid, cinnamic acid or 10-undecenoic acid.
  • Also suitable as compounds b) are straight-chain or branched, linear or cyclic, aliphatic or aromatic hydrocarbons which have at least two double bonds which may not be conjugated in aliphatic hydrocarbons, eg. B. divinylbenzene, divinyltoluene, 1, 7-octadiene, 1, 9-decadiene, A-vinyl-1-cyclohexene, trivinylcyclohexane or polybutadienes having molecular weights of 200 to 20,000.
  • Suitable compounds (b) are the acrylic acid amides, methacrylic acid amides and N-allylamines of at least divalent amines.
  • Such amines are, for example, 1,2-diaminomethane, 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,6-diaminohexane, 1,12-dodecanediamine, piperazine, diethylenetriamine or isophoronediamine.
  • amides of allylamine and unsaturated carboxylic acids such as acrylic acid, methacrylic acid, itaconic acid, maleic acid, or at least dibasic carboxylic acids, as described above.
  • N-vinyl compounds of urea derivatives at least divalent amides, cyanurates or urethanes, for example of urea, ethylene urea, propylene urea or tartaramide, for. N, N'-divinylethyleneurea or N, N'-divinylpropyleneurea.
  • Further suitable compounds b) are divinyldioxane, tetraallylsilane or tetravinylsilane.
  • mixtures of the abovementioned compounds b) can also be used.
  • Very particularly preferred compounds b) are ethylene glycol di (meth) acrylate, polyethylene glycol di (meth) acrylates, pentaerythritol triallyl ether, methylenebisacrylamide, N, N'-divinylethyleneurea, triallylamine, trimethylolpropane tri (meth) acrylate and triallylmonoalkylammonium salts.
  • the molar ratio of compound a) to compound b) is generally in the range from 1: 2 to 1:10, preferably in the range from 1: 2 to 1: 4, very particularly preferably in the range from 1: 2.5 to 1: 3.5 and in particular in the range of 1: 2.8 to 1: 3.2.
  • the new polymers described herein are in the presence of the active ingredient (template) via a precipitation polymerization with a large solvent excess (weight ratio of solvent to active ingredient in the range of 100: 1 to 5: 1, preferably from 100: 1 to 50: 1, especially preferably 59: 1) in a batch or semi-batch process.
  • the recovered polymer particles are purified by Soxhlet extraction. After the active binding sites (the molecular imprints) have been re-loaded with the template (or if template extraction has been dispensed with after polymer synthesis), the polymer can be used to release the cosmetic drug in a controlled manner.
  • the preparations according to the invention are characterized in that the release rate for the active ingredient from the polymer / active substance complex at pH 5 is higher than at pH 7.
  • the polymer / active substance complex is obtained when the polymer has been embossed with the active ingredient and subsequently unbound drug was removed or previously embossed and released from bound drug polymer is loaded with drug again.
  • Release rate is understood to mean the amount of active substance which is released from the polymer / active substance complex per unit of time; the rate can be given in ⁇ g * min- 1 , for example.
  • the release rate is determined as follows: an ultrafiltration cell is filled with a dispersion of 100 mg of the molecularly imprinted polymer in 100 ml of water (with adjusted pH) and stirred for 15 minutes until homogenized.
  • the extractant also water with the same adjusted pH
  • the extract emerging from the cell is directed to the bottom of the cell in a collecting vessel.
  • Trial period 12 hours; Replacement of the collecting vessel: every 60 minutes; 12 fractions are collected over the trial period.
  • the volume, mass and withdrawal period of the individual fractions are determined and a 2 ml sample is taken from each fraction. These samples are filtered through a 0.45 ⁇ l filter, filled into injection bottles and used for tocopherol determination by HPLC.
  • the present invention also encompasses the process for preparing the molecularly imprinted polymers, which is characterized in that the polymer is prepared by precipitation polymerization in the presence of an active substance.
  • the basic principle of precipitation polymerization is known to those skilled in the art and is described, for example, in Guyot, A. (1989), in: Comprehensive Polymer Science, Vol. 4: Eastmond, G. C, Ledwith, A., Russo, S., Sigwalt, P. (Eds.). Oxford: Pergamon, pp. 261-273.
  • the molecularly imprinted polymer may be prepared by
  • the polymerization can be carried out in a radical, anionic, cationic or coordinative mechanism or according to the principle of a polycondensation or polyaddition. Preferably, it is polymerized via a free-radical mechanism.
  • Various initiators and / or catalysts can be used, if appropriate also in combination with heat supply.
  • cationic polymerizations for example, the following initiators can be used:
  • Protic acids Lewis acids with and without coinitiators, carbonium ions, iodonium ions and / or ionizing radiation
  • the following initiators can be used: bases, Lewis bases, organometallic compounds and / or electron transfer agents, e.g. Alkali metals, alkali metal-aromatic complexes, metal ketyls
  • the following initiators / catalysts can be used:
  • Zero-complexes with transition metals eg metallocenes and / or activated transition metal oxides
  • Initiators which are suitable for the preferred free-radical polymerization are, for example, peroxides or azo compounds, substituted ethanes (for example benzopinacols), redox systems with inorganic and organic components, heat, UV light and other high-energy radiation, hydroperoxides, peresters and persulfates, for example potassium peroxodisulfate. preferably azo compounds.
  • Suitable azo compounds are 2,2'-azobisisobutyronitrile, 2,2'-azobis (2-methylbutyronitrile), 2,2'-azobis (2,4-dimethylvaleronitrile), 2,2'-azobis (4-methoxy-2,4 dimethylvaleronitrile), 1, 1'-azobis (1-cyclohexanecarbonitrile), 2,2'-azobis (isobutyramide) dihydrate, 2-phenylazo-2,4-dimethyl-4-methoxyvaleronitrile, dimethyl 2,2'-azobisisobutyrate, 2- (carbarmoylazo) isobutyronitrile, 2,2'-azobis (2,4,4-trimethylpentane), 2,2'-azobis (2-methylpropane), 2,2'-azobis (N, N'-dimethyleneisobutyramidine), as the free base or as the hydrochloride, 2,2'-azobis (2-amidinopropane), as the free base or as the hydro
  • Suitable peroxides are, for example, acetylcyclohexanesulphonic peroxide, diisopropyl peroxydicarbonate, t-amylperneodecanoate, t-butylperneodecanoate, t-butylperpivalate, tamylperpivalate, bis (2,4-dichlorobenzoic acid) peroxide, dionononanoic acid peroxide, di-decanoic acid peroxide, dioctanoic peroxide, dilaurylic acid - roxide, bis (2-methylbenzoic acid) peroxide, disuccinic acid peroxide, diacetyl peroxide, dibenzoic acid peroxide, t-butyl per-2-ethylhexanoate, bis (4-chlorobenzoic acid) peroxide, t-butyl perisobutyrate, t-butyl permaleinate, 1,1
  • the crosslinker may be added in solid, liquid form to the reaction mixture or dissolved or dispersed in a solvent (ie emulsified or suspended), preferably added dissolved.
  • a liquid crosslinker or a crosslinker dissolved (or dispersed / mixed) in a solvent is added to the reaction mixture, more preferably a crosslinker dissolved (or dispersed / mixed) in a solvent.
  • the crosslinker is dissolved in the same solvent as the functional monomer or crosslinker.
  • organic solvents may be used, for example, dimethylformamide, ethanol, methanol, isopropanol, chloroform, dichloromethane, toluene, dimethylsulfoxide, hexane and acetonitrile, preferably toluene and acetonitrile. It is also possible to use mixtures of the abovementioned solvents.
  • up to a proportion of 50% by weight of water may be added to the solvent or the solvent mixtures.
  • MIP All embodiments of the above-mentioned particles are hereinafter referred to as "MIP”.
  • the particles obtained during the polymerization can either be used directly in the formulations or mixed with formulation auxiliaries and formulated accordingly.
  • Another object of the present invention is the use of molecularly imprinted polymers in cosmetic preparations, in particular skin cosmetic preparations
  • Another object of the present invention is a method for the treatment of Keratinober romance, characterized in that the Keratinober Structure is brought into contact with a molecularly imprinted polymer.
  • the preparations according to the invention contain cosmetically acceptable active ingredients. These active substances are released in a controlled manner, in particular in the pH range from 5 to 7, from the combination with the polymer molecularly imprinted with this active substance.
  • the active ingredients can be advantageously selected from the group consisting of acetylsalicylic acid, atropine, azulene, hydrocortisone and its derivatives, for.
  • hydrocortisone 17-valerate vitamins of the B and D series, especially vitamin Bi, vitamin B12, vitamin D, vitamin A or its derivatives such as retinyl palmitate, vitamin E or its derivatives such as tocopheryl acetate, vitamin C.
  • vitamin F unsaturated fatty acids
  • ⁇ -linolenic acid eicosapentaenoic acid, docosahexaenoic acid and its derivatives
  • chloramphene nicol caffeine, prostaglandins, thymol, camphor, squalene, extracts or other products of plant and animal origin, eg evening primrose oil, borage oil or Johanisbeerkernöl, fish oils, cod liver oil but also ceramides and ceramide-like compounds
  • frankincense extract green tea extract, water-lily extract, licorice extract, mamelis
  • anti-dandruff active ingredients eg, selenium disulfide, zinc pyrithione, piroctone, o
  • the active substance (s) can also be selected from the group of NO synthase inhibitors, in particular when the compositions according to the invention are used for the treatment and prophylaxis of the symptoms of intrinsic and / or extrinsic skin aging and for the treatment and prophylaxis of the harmful effects of ultraviolet radiation on the skin and hair should serve.
  • Preferred NO synthase inhibitor is nitroarginine.
  • the active ingredient (s) are selected from the group comprising catechins and bile acid esters of catechins and aqueous or organic extracts from plants or plant parts which have a content of catechins or bile acid esters of catechins, such as the leaves of the plant family Theaceae, in particular of the species Camellia sinensis (green tea).
  • catechins and bile acid esters of catechins are selected from the group comprising catechins and bile acid esters of catechins and aqueous or organic extracts from plants or plant parts which have a content of catechins or bile acid esters of catechins, such as the leaves of the plant family Theaceae, in particular of the species Camellia sinensis (green tea).
  • Particularly advantageous are their typical ingredients (e.g., polyphenols or catechins, caffeine, vitamins, sugars, minerals, amino acids, lipids).
  • Catechins represent a group of compounds which are to be regarded as hydrogenated flavones or anthocyanidins and derivatives of "catechin” (catechol, 3, 3 ', 4', 5,7-flavanpentaol, 2- (3,4-dihydroxyphenyl) -chroman
  • epicatecine ((2R, 3R) -3,3 ', 4', 5,7-flavanpentaol) is an advantageous active ingredient in the context of the present invention.
  • herbal extracts containing catechins especially extracts of green tea, such as. B. extracts from leaves of the plants of the species Camellia spec, especially the teas Camellia sinenis, C. assamica, C. taliensis and C. inawadiensis and crosses of these with, for example, Camellia japonica.
  • active substances are polyphenols or catechins from the group (-) - catechin, (+) - catechin, (-) - catechin gallate, (-) - gallocatechin gallate, (+) - epicatechin, (-) - epicatechin, (-) Epicatechin gallate, (-) - epigallocatechin, (-) - epigallocatechin gallate.
  • flavone and its derivatives are advantageous active ingredients in the sense of the present invention and are characterized by the following basic structure (substitution positions indicated):
  • flavones usually occur in glycosidated form.
  • the flavonoids are preferably selected from the group of substances of the general formula
  • Zi to Z 7 independently of one another, are selected from the group consisting of H, OH, alkoxy and hydroxyalkoxy, where the alkoxy or hydroxyalkoxy groups can be branched and unbranched and can have 1 to 18 C atoms, and where GIy is selected is selected from the group of mono- and oligoglycoside radicals.
  • the flavonoids can also be chosen advantageously from the group of substances of the general formula
  • Zi to Z & independently selected from the group H, OH, alkoxy and hydroxyalkoxy, wherein the alkoxy or hydroxyalkoxy groups may be branched and unbranched and have 1 to 18 carbon atoms, and wherein GIy is selected from the Group of mono- and oligoglycoside residues.
  • such structures can be selected from the group of substances of the general formula
  • Gly2 and GIV3 independently represent monoglycoside residues or oligoglycoside residues.
  • Gly2 or Gly3 can also individually or together represent hydrogen saturation.
  • Gly-i, Gly2 and Gly3 are independently selected from the group of Hexosylreste, in particular the Rhamnosylreste and Glucosylreste.
  • Hexosylreste in particular the Rhamnosylreste and Glucosylreste.
  • other hexosyl radicals for example allosyl, altrosyl, galactosyl, gulosyl, idosyl, mannosyl and talosyl, may also be advantageous to use.
  • Zi to Z5 are independently selected from the group H, OH, methoxy, ethoxy and 2-hydroxyethoxy, and the flavone glycosides correspond to the general structural formula
  • the flavone glycosides are selected from the group represented by the following structure.
  • Glyi, Gly2 and Gly3 independently represent monoglycoside residues or oligoglycoside residues. Gly2 or Gly3 can also represent individually or jointly saturations by hydrogen atoms.
  • Glyi, Gly2 and Gly3 are independently selected from the group of Hexosylreste, in particular the Rhamnosylreste and Glucosylreste.
  • Hexosylreste in particular the Rhamnosylreste and Glucosylreste.
  • other hexosyl radicals for example allosyl, altrosyl, galactosyl, gulosyl, idosyl, mannosyl and talosyl, may also be advantageous to use.
  • the flavone glycoside (s) from the group ⁇ -glucosylrutin, ⁇ -glucosylmyricetin, ⁇ -glucosylisoquercitrin, ⁇ -glucosylisoquercetin and ⁇ -glucosylquercitrin.
  • beneficial agents are sericoside, pyridoxol, vitamin K, biotin and flavorings.
  • active compounds can also be chosen very advantageously from the group of hydrophilic active substances, in particular from the following group:
  • ⁇ -hydroxy acids such as lactic acid or salicylic acid or salts thereof such as e.g. N / A-
  • the active compounds can also be chosen very advantageously from the group of light filter active ingredients.
  • Suitable light filter active substances are substances which absorb UV rays in the UV-B and / or UV-A range. These are understood to mean organic substances which are able to absorb ultraviolet rays and to release the absorbed energy in the form of longer-wave radiation, eg heat.
  • the organic substances may be oil-soluble or water-soluble.
  • Suitable UV filters are, for example, 2,4,6-triaryl-1,3,5-triazines, in which the aryl groups can each carry at least one substituent, which is preferably selected from hydroxy, alkoxy, especially methoxy, alkoxycarbonyl, especially Methoxycarbonyl and ethoxycarbonyl.
  • p-aminobenzoic acid esters p-aminobenzoic acid esters, cinnamic acid esters, benzophenones, camphor derivatives and UV-blocking pigments, such as titanium dioxide, talc and zinc oxide. Particular preference is given to pigments based on titanium dioxide.
  • UV-B filters e.g. the following substances are used: 3-benzylidene camphor and its derivatives, e.g. 3- (4-methylbenzylidene) camphor;
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and 4- (dimethylamino) benzoic acid ester;
  • esters of cinnamic acid preferably 2-ethylhexyl 4-methoxycinnamate, 4-propyl methoxy cinnamate, isoamyl 4-methoxycinnamate, 4-isoacetyl methoxycinnamate, 2-cyano-3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
  • Esters of salicylic acid preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • Esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
  • Triazine derivatives such as 2,4,6-trianilino- (p-carbo-2'-ethyl-1 '-hexyloxy) -1, 3,5-triazine (octyl tyltriazone) and Dioctyl Butamido Triazone (Uvasorb HEB ®):
  • Propane-1,3-diones e.g. 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione.
  • Suitable water-soluble substances are:
  • Sulfonic acid derivatives of the 3-benzylidene camphor e.g. 4- (2-Oxo-3-bornylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) -sulfonic acid and its salts.
  • esters of cinnamic acid preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid isopentyl ester, 2-cyano-3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene).
  • Typical UV-A filters are:
  • benzoylmethane such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl-4'-methoxydibenzoylmethane or 1-phenyl-3 - (4'-isopropylphenyl) -propane-1,3-dione;
  • Amino-hydroxy-substituted derivatives of benzophenones e.g. N, N-diethylamino-hydroxybenzoyl-n-hexylbenzoate.
  • UV-A and UV-B filters can also be used in mixtures.
  • secondary light stabilizers of the antioxidant type which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates into the skin.
  • Typical examples are superoxide dismutase, catalase, tocopherols (vitamin E) and ascorbic acid (vitamin C).
  • anti-irritants which have an anti-inflammatory effect on UV-damaged skin.
  • anti-irritants which have an anti-inflammatory effect on UV-damaged skin.
  • Such substances are, for example, bisabolol, phytol and phytantriol.
  • compositions according to the invention should, of course, not be limiting.
  • active substances can be used individually or in any desired combinations with one another.
  • the amount of such active ingredients (one or more compounds) in the compositions according to the invention is preferably 0.001 to 30 wt .-%, more preferably 0.05 to 20 wt .-%, in particular 1 to 10 wt .-%, based on the total weight of the composition.
  • the weight ratio of molecular weight-embossed polymer to active ingredient is in the range from 1:10 to 100: 1, preferably from 1: 1 to 10: 1, more preferably from 4: 1 to 5: 1 and in particular 4: 1.
  • the preparations according to the invention comprise at least one fatty phase.
  • fat phase is meant all cosmetically acceptable oils, fats and / or waxes.
  • ingredients are preferably selected from the group of natural or synthetic polymers, pigments, humectants, oils, waxes, enzymes, minerals, vitamins, sunscreens, dyes, perfumes, antioxidants, preservatives and / or pharmaceutical agents.
  • auxiliaries and additives for the production of skin cosmetic preparations are familiar to the expert and can from manuals of cosmetics, such as Schrader, bases and formulations of cosmetics, Weghig Verlag, Heidberg, 1989, ISBN 3-7785-1491-1, or Limbach, cosmetics: development, production and application of ksometischer means, 2nd extended edition, 1995, Georg Thieme Verlag, ISBN 3 13 712 602 9 are removed.
  • the use of the active ingredient molecularly imprinted polymers according to the invention in dermocosmetics is carried out in combination with at least one different constituent selected from cosmetically active ingredients, emulsifiers, surfactants, preservatives, perfume oils, thickeners, hair polymers, hair and skin conditioners, graft polymers, water-soluble or dispersible silicone-containing polymers, light stabilizers, bleaching agents, gelling agents, care products, colorants, tinting agents, tanning agents, dyes, pigments, bodying agents, moisturizers, restoats, collagen, protein hydrolysates, lipids, antioxidants, defoamers, antistatic agents, emollients and plasticizers.
  • cosmetically active ingredients emulsifiers, surfactants, preservatives, perfume oils, thickeners, hair polymers, hair and skin conditioners, graft polymers, water-soluble or dispersible silicone-containing polymers, light stabilizers, bleaching agents, gelling agents, care products, colorants,
  • the antioxidants are selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazolones (eg urocaninic acid) and derivatives thereof, peptides such as D, L-carnosine, D-carnosine, L-carnosine.
  • amino acids eg glycine, histidine, tyrosine, tryptophan
  • imidazolones eg urocaninic acid
  • peptides such as D, L-carnosine, D-carnosine, L-carnosine.
  • Carnosine and its derivatives eg anserine
  • carotenoids eg .beta.-carotene, lycopene
  • chlorogenic acid and its derivatives eg dihydrolipoic acid
  • lipoic acid and derivatives thereof eg dihydrolipoic acid
  • aurothioglucose propylthiouracil and other thiols
  • vitamins, provitamins or vitamin precursors of the vitamin B group or derivatives thereof which may preferably be used according to the invention and the derivatives of 2-furanone include, inter alia:
  • Vitamin Bi common name thiamine, chemical name 3 - [(4'-amino-2'-methyl-5'-pyrimidinyl) methyl] -5- (2-hydroxyethyl) -4-methylthiazolium chloride.
  • Vitamin B2 common name riboflavin, chemical name 7,8-dimethyl-10- (1-D-ribityl) -benzo [g] pteridine-2,4 (3H, 10H) -dione.
  • riboflavin z As in whey, other riboflavin derivatives can be isolated from bacteria and yeasts.
  • a stereoisomer of riboflavin which is likewise suitable according to the invention is the lyxoflavin which can be isolated from fish meal or liver and carries a D-arabityl residue instead of the D-ribityl residue.
  • Vitamin B3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • the nicotinic acid amide is preferred according to the invention.
  • Vitamin B5 pantothenic acid and panthenol
  • Panthenol is preferably used.
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols.
  • Particularly preferred derivatives are the commercially available substances dihydro-3-hydroxy-4,4- dimethyl-2 (3H) -furanone with the common name pantolactone (Merck), 4 hydroxymethyl- ⁇ -butyrolactone (Merck), 3,3-dimethyl-2-hydroxy- ⁇ -butyrolactone (Aldrich) and 2,5-dihydro-5 -methoxy-2-furanone (Merck), expressly including all stereoisomers.
  • these compounds impart moisturizing and soothing properties to the dermocosmetics of the invention.
  • Vitamin B 6 which is understood here not a single substance, but the known under the common names pyridoxine, pyridoxamine and pyridoxal derivatives of 5-hydroxymethyl-2-methylpyridin-3-ols.
  • Vitamin B 7 also known as vitamin H or "skin vitamin”.
  • Biotin is (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid.
  • Panthenol, pantolactone, nicotinamide and biotin are very particularly preferred according to the invention.
  • Dyes Dyestuffs which may be used are the substances suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Kosmetician Anlagenrbesch” of the Farbstoffkommission of the Irish Anlagenscade, published by Verlag Chemie, Weinheim, 1984. These dyes are usually used in concentrations of 0.001 to 0.1 wt .-%, based on the total mixture.
  • the compositions according to the invention contain at least one pigment.
  • the pigments are present in the product composition in undissolved form and may be present in an amount of from 0.01 to 25% by weight, more preferably from 5 to 15% by weight.
  • the preferred particle size is 1 to 200 .mu.m, in particular 3 to 150 .mu.m, particularly preferably 10 to 100 .mu.m.
  • the pigments are practically insoluble colorants in the application medium and may be inorganic or organic. Also inorganic-organic mixed pigments are possible. Preference is given to inorganic pigments.
  • the advantage of inorganic pigments is their excellent light, weather and temperature resistance.
  • the inorganic pigments may be of natural origin, for example made of chalk, ocher, umber, green soil, terraced terraza or graphite.
  • the pigments may be white pigments such as titanium dioxide or zinc oxide, black pigments such as iron oxide black, colored pigments such as ultramarine or iron oxide red, luster pigments, metallic effect pigments, pearlescent pigments, as well as fluorescence or phosphorescent pigments, wherein preferably at least one pigment is a colored, non-white pigment.
  • Suitable are metal oxides, hydroxides and oxide hydrates, mixed phase pigments, sulfur-containing silicates, metal sulfides, complex metal cyanides, metal sulfates, chromates and molybdate and the metals themselves (bronze pigments).
  • Titanium dioxide (Cl 77891), black iron oxide (Cl 77499), yellow iron oxide (Cl 77492), red and brown iron oxide (Cl 77491), manganese violet (Cl 77742), ultramarines (sodium aluminum sulfosilicates, Cl 77007, Pigment Blue 29 ), Chromium oxide hydrate (C177289), iron blue (Ferric Ferro-Cyanide, CI7751 0), Carmine (Cochineal).
  • pearlescent and color pigments based on mica or mica which are coated with a metal oxide or a metal oxychloride such as titanium dioxide or bismuth oxychloride and optionally further coloring substances such as iron oxides, iron blue, ultramarines, carmines, etc., and the color is determined by varying the layer thickness can be.
  • a metal oxide or a metal oxychloride such as titanium dioxide or bismuth oxychloride and optionally further coloring substances such as iron oxides, iron blue, ultramarines, carmines, etc.
  • Such pigments are sold, for example under the trade names Rona ®, Colorona ®, Dichrona and Timiron ® ® (Merck).
  • Organic pigments include, for example, the natural pigments sepia, cambogia, bone charcoal, Kasseler brown, indigo, chlorophyll and other plant pigments.
  • Synthetic organic pigments include azo pigments, anthraquinoids, indigoids, dioxazine, quinacridone, phthalocyanine, isoindolinone, perylene and perinone, metal complex, alkali blue and diketopyrrolopyrrole pigments.
  • the use of the active-molecular-embossed polymers according to the invention or prepared according to the inventive process with at least one particulate substance in the composition in a proportion of 0.01 to 10, preferably from 0.05 to 5 wt. % is present.
  • Suitable substances are e.g. Substances which are solid at room temperature (25 ° C) and in the form of particles. Suitable examples are silica, silicates, aluminates, clays, mica, salts, in particular inorganic metal salts, metal oxides, e.g. Titanium dioxide, minerals and polymer particles.
  • the particles are present in the agent undissolved, preferably stably dispersed form and can be deposited in solid form after application to the application surface and evaporation of the solvent.
  • Preferred particulates are silica (silica gel, silica) and metal salts, especially inorganic metal salts, with silica being particularly preferred.
  • Metal salts are e.g. Alkali or alkaline earth halides such as sodium chloride or potassium chloride; Alkali or alkaline earth sulfates such as sodium sulfate or magnesium sulfate.
  • suitable pearlescing agents are: alkylene glycol esters, special ethylene glycol disterate; Fatty acid alkanolamides, especially coconut fatty acid diethanoamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, if hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which in total have at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring-opening products of olefin epoxides having 12 to 22 carbon atoms with fatty alcohols having 12 to 22 carbon atoms and / or polyols having 2 to 15 carbon atoms and 2 to 10 hydroxy
  • Typical thickeners in such formulations are crosslinked polyacrylic acids and their derivatives, polysaccharides and their derivatives, such as xanthan gum, agar-agar, alginates or tyloses, cellulose derivatives, e.g. Carboxymethylcellulose or hydroxycarboxymethylcellulose, fatty alcohols, monoglycerides and fatty acids, polyvinyl alcohol and polyvinylpyrrolidone.
  • Nonionic thickeners are preferably used.
  • Suitable cosmetically and / or dermocosmetically active agents are e.g. coloring agents, skin and hair pigmentation agents, tinting agents, suntanning agents, bleaching agents, keratin-hardening substances, antimicrobial agents, light-filtering active ingredients, repellent active ingredients, hyperemic substances, keratolytic and keratoplasmic substances, antiperspirants, antiphlogistics, keratinizing substances, antioxidant or radical scavengers active ingredients, skin moisturizing or moisturizing substances, moisturizing agents, antierythimatös or antiallergically active ingredients, branched fatty acids such as 18-Methyleicosanklare, and mixtures thereof.
  • coloring agents e.g. coloring agents, skin and hair pigmentation agents, tinting agents, suntanning agents, bleaching agents, keratin-hardening substances, antimicrobial agents, light-filtering active ingredients, repellent active ingredients, hyperemic substances, keratolytic and keratoplasmic substances
  • Artificial skin tanning agents which are suitable for tanning the skin without natural or artificial irradiation with UV rays are e.g. Dihydroxyacetone, alloxan and walnut shell extract.
  • Suitable keratin-hardening substances are, as a rule, active ingredients as are also used in antiperspirants, such as, for example, antiperspirants. Potassium aluminum sulfate, aluminum hydroxychloride, aluminum lactate, etc.
  • Antimicrobial agents are used to destroy microorganisms or to inhibit their growth and thus serve both as a preservative and as a deodorizing substance, which reduces the formation or intensity of body odor.
  • These include e.g. customary preservatives known to the person skilled in the art, such as p-hydroxybenzoic acid ester, imidazolidinyl urea, formaldehyde, sorbic acid, benzoic acid, salicylic acid, etc.
  • deodorizing substances are known, for example. Zinc ricinoleate, triclosan, undecylenic acid alkylolamides, citric acid triethyl ester, chlorhexidine etc.
  • Table 4 suitable preservatives.
  • the E numbers listed in the above table are the drawings used in Directive 95/2 / EEC.
  • preservative additives dibromodicyanobutane (2-bromo-2-bromomethylglutarodinitrile), 3-iodo-2-propynyl butylcarbamate, 2-bromo-2-nitropropane-1,3-diol, imidazo - lidinyl urea, 5-chloro-2-methyl-4-isothiazolin-3-one, 2-chloroacetamide, benzalkonium chloride and benzyl alcohol suitable.
  • phenylhydroxyalkyl ethers in particular the compounds known as phenoxyethanol, are suitable as preservatives because of their bactericidal and fungicidal effects on a number of microorganisms.
  • germ-inhibiting agents are also suitable for incorporation into the preparations according to the invention.
  • Advantageous substances are, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether (Irgasan), 1, 6-di- (4-chlorphenylbiguanido) - hexane (chlorhexidine), 3,4,4'-trichlorocarbanilide, quaternary ammonium compounds , Clove oil, mint oil, thyme oil, triethyl citrate, farnesol (3,7,11-trimethyl-2,6,10- dodecat ⁇ en-1-ol) and in the patent publications DE-37 40 186, DE-39 38 140, DE-42 04 321, DE-42 29 707, DE-43 09 372, DE-44 11 664, DE-195 41 967, DE-195 43 695, DE-195 43 696, DE-195 47 160, DE-196 02 108, DE-196 02 110, DE-196 02 11 1, DE-196 31
  • the cosmetic compositions may contain perfume oils.
  • perfume oils for example, mixtures of natural and synthetic fragrances may be mentioned.
  • Natural fragrances are extracts of flowers (lily, lavender, rose, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (aniseed, coriander, caraway, juniper), fruit peel (bergamot, Lemon, orange), roots (macis, angelica, celery, cardamom, costus, iris, calmus), woods (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme ), Needles and twigs (spruce, fir, pine, pines), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are ester type products, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, 4-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linalyl benzoate, benzylformate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrene-propionate and benzylsalicylate.
  • the ethers include, for example, benzyl ether ethers, to the aldehydes, for example, the alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonate, to the ketones, for example the ionones, cc-isomethyl ions and methylatedrylketone,
  • the alcohols include anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terioneol; the hydrocarbons mainly include the terpenes and balsams.
  • fragrances are used, which together produce an attractive fragrance.
  • Lower volatile volatiles which are most commonly used as aroma components, are also suitable as perfume oils, eg sage oil, camomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galaban oil, labolanum oil and lavandin oil.
  • compositions of the invention contain at least one fatty phase.
  • fat phase is meant oils, fats and / or waxes.
  • Ingredients of the oil and / or fat phase of the compositions of the invention are advantageously selected from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 8 to 24, in particular 12 to 18 C. -atoms.
  • the fatty acid triglycerides can be advantageously selected from the group of synthetic, semi-synthetic and natural oils, such as e.g.
  • Olive oil sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grapeseed oil, thistle oil, evening primrose oil, macadamia nut oil, and the like.
  • polar oil components can be selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms and from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms.
  • ester oils can then advantageously be selected from the group isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2
  • one or more oil components can be advantageously selected from the group of branched and unbranched hydrocarbons and waxes, the SiI konöle, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols. Any mixtures of such oil and wax components are also advantageous to use in the context of the present invention. It may also be advantageous, if appropriate, to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.
  • the oil component is advantageously selected from the group 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C12-15-alkyl benzoate, caprylic capric acid triglyceride, dicaprylyl ether.
  • Advantageous in accordance with the invention are mixtures of C 12-15 -alkyl benzoate and 2-ethylhexyl isostearate, mixtures of C 12-15 -alkylbenzoate and 2-ethylhexyl isostearate.
  • paraffin oil, squalane and squalene are to be used advantageously in the context of the present invention.
  • the oil phase can advantageously be chosen from the group of Guerbet alcohols.
  • Guerbet alcohols are named after Marcel Guerbet, who first described their production. They arise according to the reaction equation
  • Guerbet alcohols Catalyst by oxidation of an alcohol to an aldehyde, by aldol condensation of the aldehyde, elimination of water from the aldol and hydrogenation of allyl aldehyde.
  • Guerbet alcohols are fluid even at low temperatures and cause virtually no skin irritation.
  • they can be used as greasing, overfatting and also re-greasing ingredients in cosmetic compositions.
  • Ri and R2 are generally unbranched alkyl radicals.
  • the Guerbet alcohol or alcohols are selected from among
  • Ri propyl, butyl, pentyl, hexyl, heptyl or octyl and
  • R2 hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl or tetradecyl.
  • Guerbet alcohols are 2-butyl (for example as lsofol ® 12 (Condea) commercially available) and 2-hexyl decanol (for example as iso- fol ® 16 (Condea) commercially available).
  • mixtures of Guerbet alcohols are according to the invention may advantageously be used such as mixtures of 2-butyloctanol and 2-hexyl decanol (for example as lsofol ® 14 (Condea) commercially available).
  • the oil component may further comprise a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or silicone oils.
  • Low molecular weight silicones or silicone oils are generally defined by the following general formula:
  • silicon atoms may be substituted by identical or different alkyl radicals and / or aryl radicals, which are here generalized by radicals R 1 to R 4 .
  • radicals R 1 to R 4 the number of different radicals is not necessarily limited to 4, m may assume values of 2 to 200,000.
  • silicon atoms can be substituted with identical or different alkyl radicals and / or aryl radicals, which are here generalized by the radicals Ri to R 4 .
  • the number of different residues is not necessarily limited to 4, and "n" may be 3/2 to 20. Broken values for n take into account that odd numbers of siloxyl groups may be present in the cycle.
  • phenyltrimethicone is chosen as the silicone oil.
  • Other silicone oils for example, dimethicone, hexamethylcyclotrisiloxane, phenyldimethicone, cyclomethicone (octamethylcyclotetrasiloxane), hexamethylcyclotrisiloxane, polydimethylsiloxane, polyoxyethylene ly (methylphenylsiloxane), cetyl dimethicone, behenoxydimethicone are to be used advantageously in the context of the present invention.
  • silicone oils of similar constitution as the compounds described above, whose organic side chains are derivatized, for example polyethoxylated and / or polypropoxylated.
  • silicone oils include, for example Polysiloxanpolyalkyl-polyether copolymers such as cetyl dimethicone copolyol.
  • Cyclomethicone octamethylcyclo-tetrasiloxane is advantageously used as the silicone oil to be used according to the invention.
  • Fat and / or wax components which can advantageously be used according to the invention can be selected from the group of vegetable waxes, animal waxes, mineral waxes and petrochemical waxes.
  • candelilla wax, carnauba wax, Japan wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, berry wax, ouricury wax, montan wax, jojoba wax, shea butter, beeswax, shellac wax, spermaceti, lanolin (wool wax), crepe fat, ceresin, ozokerite (earth wax) are advantageous ), Paraffin waxes and microwaxes.
  • fat and / or wax components are chemically modified waxes and synthetic waxes, such as Syncrowax ® (glyceryl tribehenate), and Syncrowax ® AW 1 C (C is-36- fatty acid) as well as Montanesterwachse, sasol waxes, hydrogenated jojoba , synthetic or modified beeswaxes (z. B. dimethicone copolyol beeswax and / or C3o-so-alkyl beeswax), cetyl ricinoleates leate such as Tegosoft ® CR, polyalkylene waxes, polyethylene glycol waxes, but also chemically modified fats such.
  • Syncrowax ® glycol waxes
  • Syncrowax ® AW 1 C C is-36- fatty acid
  • Montanesterwachse sasol waxes
  • sasol waxes hydrogenated jojoba
  • Hydrogenated castor oils for example hydrogenated castor oil and / or hydrogenated coconut fat glycerides
  • triglycerides such as, for example, hydrogenated soy glyceride, trihydroxystearin, fatty acids, fatty acid esters and glycol esters such as, for example, C2o-4-alkyl stearate, C2o-4-alkylhydroxy-stearyl stearate and / or glycol montanate.
  • Other advantageous compounds are certain organosilicon compounds which have similar physical properties to the abovementioned fatty and / or wax components, for example stearoxytrimethylsilane.
  • the fat and / or wax components can be used both individually and as a mixture in the compositions.
  • the oil phase is selected from the group consisting of 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, butylene glycol di-caprylate / dicaprate, 2-ethylhexyl cocoate, C 12 -is alkyl benzoate, caprylic capric acid triglyceride, dicaprylyl ether.
  • Particularly advantageous are mixtures of octyldodecanol, caprylic-capric triglyceride, dicaprylyl ether, dicaprylyl carbonate, cocoglycerides or mixtures of Ci2-is-alkyl benzoate and 2-Ethylhexylisostearat, mixtures of Ci 2 - 1 5-alkyl benzoate and butylene glycol dicaprylate / dicaprate and mixtures C12 - 1 5-benzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate.
  • paraffin oil paraffin oil, cycloparaffin, squalane, squalene, hydrogenated polyisobutene or polydecene are to be used advantageously in the context of the present invention.
  • the oil component is also advantageously selected from the group of phospholipids.
  • the phospholipids are phosphoric acid esters of acylated glycerols.
  • the lecithins which are distinguished by the general structure
  • the active substance / molecular imprinted polymers according to the invention or produced according to the inventive process are used in cosmetic or dermatological preparations which are a solution or emulsion or dispersion, the following can be used as solvent:
  • Oils such as triglycerides of capric or capric acid, but preferably castor oil
  • Fats, waxes and other natural and synthetic fatty substances preferably esters of fatty acids with lower C-number alcohols, for example with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with lower C-number alkanoic acids or with fatty acids
  • mixtures of the abovementioned solvents are used.
  • water can be another ingredient.
  • compositions may also contain surfactants in addition to the active-molecular-embossed polymers according to the invention or produced according to the inventive method.
  • surfactants are, for example: phosphoric esters and salts, such as, for example, DEA-oleth-10-phosphate and dilaureth-4-phosphate,
  • Alkyl sulfonates for example sodium coconut monoglyceride sulfate, sodium C 12-14 olefin sulfonate, sodium lauryl sulfoacetate and magnesium PEG-3 cocamide sulfate,
  • Carboxylic acids and derivatives such as, for example, lauric acid, aluminum stearate, magnesium alkoxide and zinc undecylenate, ester carboxylic acids, for example calcium stearyl lactylate, laureth-6 citrate and sodium PEG-4 lauramide carboxylate,
  • Ethers for example ethoxylated alcohols, ethoxylated lanolin, ethoxylated polysiloxanes, propoxylated POE ethers and alkyl polyglycosides such as lauryl glucoside, decyl glycoside and cocoglycoside.
  • compositions may also contain polysorbates in addition to the inventive or according to the inventive method produced active molecular imprinted polymers.
  • advantageous polysorbates are the
  • the compositions also contain conditioning agents.
  • Conditioning agents preferred according to the invention
  • all of the compounds described in section 4 of the International Cosmetic Ingredient Dictionary and Handbook (Volume 4, ed. RC Pepe, JA Wenninger, GN McEwen, The Cosmetic, Toiletry, and Fragrance Association, 9th Edition, 2002) are cited under Hair Conditioning Agents, Humectants, Skin Conditioning Agents, Skin Conditioning Agents Emollient, Skin Conditioning Agents Humectant, Skin Conditioning Agents-Miscellaneous, Skin Conditioning Agents- Occlusive and Skin Protectants are listed as well as all in EP-A 934 956 (p.1 1-13) under "water-soluble conditioning agent” and "oil-soluble conditioning agent.”
  • Further advantageous conditioning agents are, for example, the compounds designated as polyquaternium according to INCI (in particular Polyquaternium-1 to Polyquaternium-56).
  • Suitable conditioning agents include, for example, polymeric quaternary ammonium compounds, cationic cellulose derivatives and polysaccharides. Conditioning agents which are advantageous according to the invention can be chosen from the compounds shown in the following table.
  • guar gum quali- Terni catalyzed derivatives in particular guar hydroxypropylammonium (eg Jaguar Excel ®, Jaguar C 162 ® (Rhodia), CAS 65497-29-2, CAS 39421-75-5).
  • guar hydroxypropylammonium eg Jaguar Excel ®, Jaguar C 162 ® (Rhodia), CAS 65497-29-2, CAS 39421-75-5.
  • non-ionic poly N-vinylpyrrolidone / polyvinyl acetate copolymers eg Lu viskol ® VA 64 (BASF Aktiengesellschaft)
  • anionic acrylate copolymers for example, Lu viflex ® soft (BASF Aktiengesellschaft)
  • amphoteric amide / acrylate / methacrylate copolymers for example Amphomer.RTM ® (National Starch)
  • An addition of powder raw materials can be generally advantageous. Particularly preferred is the use of talc.
  • the compositions may also contain ethoxylated oils selected from the group consisting of ethoxylated glycerol fatty acid esters, more preferably PEG-10 olive oil glycerides, PEG-1 1 avocado oil glycerides, PEG-1 1 cocoa butter glycerides, PEG-13 sunflower oil glycerides, PEG 15 Glyceryl Isostearate, PEG-9 Coconut Fatty Acid Glycerides, PEG-54 Hydrogenated Castor Oil, PEG-7 Hydrogenated Castor Oil, PEG-60 Hydrogenated Castor Oil, Jojoba Oil Ethoxylate (PEG-26 Jojoba Grease Acids, PEG-26 Jojoba Alcohol), Glycereth-5 Cocoate, PEG -9 Coconut fatty acid glycerides, PEG-7 glyceryl cocoate, PEG-45 palm oil glycerides, PEG-35 castor oil, Olive oil PEG-7 ester, PEG-10 olive oil glycerides, PEG-1 1 avocado oil g
  • Preferred ethoxylated oils are PEG-7 glyceryl cocoate, PEG-9 coconut glycerides, PEG-40 hydrogenated castor oil, PEG-200 hydrogenated glyceryl palmat.
  • Ethoxylated glycerol fatty acid esters are used in aqueous cleaning formulations for various purposes.
  • Low ethoxylated glycerol fatty acid esters (3-12 ethylene oxide units) usually serve as a moisturizer to improve the skin feel after drying, glycerol fatty acid esters with a degree of ethoxylation of about 30-50 serve as solubilizers for non-polar substances such as perfume oils.
  • Highly ethoxylated glycerol fatty acid esters are used as thickeners. All these substances have in common that they produce a special skin sensation on the skin when diluted with water.
  • the invention also relates to the use of the active-molecular-embossed polymers according to the invention or produced according to the inventive process in combination with light stabilizers in dermocosmetic preparations.
  • These cosmetic and / or dermatological sunscreen compositions are used for cosmetic and / or dermatological light protection, furthermore for the treatment and care of the skin and / or the hair and as a make-up product in decorative cosmetics.
  • These include, for example, sunscreens, lotions, milks, oils, baisams, gels, lip care and lipsticks, masking creams and sticks, moisturizers, lotions, emulsions, face, body and hand creams, hair conditioners and rinses.
  • Sun oils are usually mixtures of various oils with one or more sunscreen filters and perfume oils.
  • the oil components are selected according to different cosmetic properties. Oils that give good fat and soft feel, such as mineral oils (eg, paraffin oils) and fatty acid triglycerides (eg, peanut oil, sesame oil, avocado oil, medium chain triglycerides) are mixed with oils that promote dispersibility and retraction improve sun oils into the skin, reduce stickiness and make the oil film permeable to air and water vapor (perspiration). These include branched-chain fatty acid esters (eg isopropyl palmitate) and silicone oils (eg dimethylsilicone). When using oils based on unsaturated fatty acids antioxidants, eg.
  • Sun oils as anhydrous formulations usually contain no preservatives.
  • Sunmilk and creams are made as oil-in-water (O / W) emulsions and as water-in-oil (W / O) emulsions.
  • O / W emulsions are easily distributed on the skin, they are usually absorbed quickly and are almost always readily washable with water.
  • W / O emulsions are more difficult to rub in, they make the skin stronger and thus look a bit stickier, but on the other hand they better protect the skin from drying out.
  • W / O emulsions are mostly waterproof.
  • the emulsion base In the case of O / W emulsions, the emulsion base, the selection of suitable light stabilizers and, if appropriate, the use of auxiliaries (eg polymers) determine the degree of water resistance.
  • auxiliaries eg polymers
  • the basics of liquid and creamy O / W emulsions are similar in theirs Composition of other usual in skin care emulsions.
  • Sunmilk should sufficiently grease the skin dried up by sun, water and wind. They must not be sticky, as this is particularly uncomfortable in the heat and in contact with sand.
  • the light stabilizers are usually based on a carrier which contains at least one oil phase. However, compositions based on water are also possible.
  • oils, oil-in-water and water-in-oil emulsions, creams and pastes, lip balm sticks or fat-free gels are contemplated.
  • Suitable emulsions also include C7W macroemulsions, O / W microemulsions or O / W / O emulsions with surface-coated titanium dioxide particles present in dispersed form, the emulsions being obtainable by phase inversion technology, according to DE-A-197 26 121.
  • Usual cosmetic adjuncts which may be considered as additives are e.g. (Co) emulsifiers, fats and waxes, stabilizers, thickeners, biogenic agents, film formers, perfumes, dyes, pearlescers, preservatives, pigments, electrolytes (e.g., magnesium sulfate) and pH regulators.
  • As stabilizers metal salts of fatty acids, e.g. Magnesium, aluminum and / or zinc stea rat be used.
  • Biogenic active ingredients are, for example, plant extracts, protein hydrolysates and vitamin complexes.
  • Typical film formers are, for example, hydrocolloids such as chitosan, microcrystalline chitosan or quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone / vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives and similar compounds.
  • Suitable light filter active substances are substances which absorb UV rays in the UV-B and / or UV-A range. By this are meant organic substances capable of absorbing ultraviolet rays and absorbing the absorbed energy in the form of longer wavelength radiation, e.g. Heat, give it up again.
  • the organic substances may be oil-soluble or water-soluble.
  • Suitable UV filters are e.g. 2,4,6-triaryl-1, 3,5-triazines, in which the aryl groups can each carry at least one substituent, which is preferably selected from hydroxy, alkoxy, especially methoxy, alkoxycarbonyl, especially methoxycarbonyl and ethoxycarbonyl.
  • p-aminobenzoic acid esters p-aminobenzoic acid esters, cinnamic acid esters, benzophenones, camphor derivatives and UV-radiation-stopping pigments, such as titanium dioxide, talc and zinc oxide. Particular preference is given to pigments based on titanium dioxide.
  • UV-B filters e.g. the following substances are used: 3-benzylidene camphor and its derivatives, e.g. 3- (4-methylbenzylidene) camphor;
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and 4- (dimethylamino) benzoic acid ester;
  • Esters of cinnamic acid preferably 2-ethylhexyl 4-methoxycinnamate, 4-propyl methoxy cinnamate, isoamyl 4-methoxycinnamate, 4-isoacetyl methoxycinnamate, 2-cyano-3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
  • Esters of salicylic acid preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • Esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
  • Triazine derivatives such as 2,4,6-trianilino- (p-carbo-2'-ethyl-r-hexyloxy) -1, 3,5-triazine (octyl tyltriazone) and Dioctyl Butamido Triazone (Uvasorb HEB ®):
  • Propane-1,3-diones e.g. 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione.
  • Suitable water-soluble substances are:
  • Sulfonic acid derivatives of benzophenones preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;
  • Sulfonic acid derivatives of the 3-benzylidene camphor e.g. 4- (2-Oxo-3-bornylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) -sulfonic acid and its salts.
  • esters of cinnamic acid preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid isopentyl ester, 2-cyano-3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene).
  • Typical UV-A filters are: Derivatives of benzoylmethane, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl-4'-methoxydibenzoylmethane or 1-phenyl-3 - (4'-isopropylphenyl) -propane-1,3-dione;
  • Amino-hydroxy-substituted derivatives of benzophenones e.g. N, N-diethylamino-hydroxybenzoyl-n-hexylbenzoate.
  • UV-A and UV-B filters can also be used in mixtures.
  • UV filter substances are mentioned in the following table.
  • secondary light stabilizers of the antioxidant type which interrupt the photochemical reaction chain which is triggered when UV radiation is present penetrates the skin.
  • Typical examples are superoxide dismutase, catalase, tocopherols (vitamin E) and ascorbic acid (vitamin C).
  • anti-irritants which have an anti-inflammatory effect on UV-damaged skin.
  • anti-irritants which have an anti-inflammatory effect on UV-damaged skin.
  • Such substances are, for example, bisabolol, phytol and phytantriol.
  • the use of the active-molecular-embossed polymers according to the invention or produced according to the inventive method in combination with UV-blocking inorganic pigments in dermokosme- tica preparations Preference is given to pigments based on metal oxides and / or other sparingly water-soluble or insoluble metal compounds selected from the group of the oxides of zinc (ZnO), titanium (TiO.sub.2), iron (eg Fe.sub.2O.sub.3), zirconium (ZrO.sub.2), silicon (SiO.sub.2), Manganese (eg MnO), aluminum (Al2O3), Cers (eg Ce2 ⁇ 3), mixed oxides of the corresponding metals and mixtures of such O xiden.
  • ZnO zinc
  • TiO.sub.2 titanium
  • iron eg Fe.sub.2O.sub.3
  • zirconium ZrO.sub.2
  • silicon SiO.sub.2
  • Manganese eg MnO
  • the inorganic pigments may be present in coated form, i. that they are superficially treated.
  • This surface treatment can be, for example, that the pigments are provided in a manner known per se, as described in DE-A-33 14 742, with a thin hydrophobic layer.
  • Suitable repellent agents are compounds capable of preventing or repelling certain animals, particularly insects, from humans. This includes e.g. 2-ethyl-1,3-hexanediol, N, N-diethyl-m-toluamide, etc.
  • Suitable hyperemic substances which stimulate the perfusion of the skin are e.g. essential oils such as mountain pine extract, lavender extract, rosemary extra kt, juniper berry extract, horse chestnut extract, birch leaf extract, hay flower extract, ethyl acetate, camphor, menthol, peppermint oil, rosemary extract, eucalyptus oil, etc.
  • Suitable keratolytic and keratoplastic substances are e.g.
  • Salicylic acid calcium thioglycolate, thioglycolic acid and its salts, sulfur, etc.
  • Suitable anti-dandruff agents are e.g. Sulfur, sulfur polyethylene glycol sorbitan monooleate, sulfur ricinol polyethoxylate, zinc pyrithione, aluminum pyrithione, etc.
  • Suitable antiphlogistic agents which counteract skin irritation are e.g. Allantoin, bisabolol, dragosantol, chamomile extract, panthenol, etc.
  • Suitable polymers are, for example, cationic polymers with the designation polyquaternium according to INCI, for example copolymers of vinylpyrrolidone / N-vinylimidazolium salts (Luvit). quat FC, Luviquat HM, Luviquat MS, Luviquat & commat, Care), copolymers of N-vinylpyrrolidone / dimethylaminoethyl methacrylate, quaternized with diethyl sulfate (Luviquat PQ 11), copolymers of N-vinylcaprolactam / N-vinylpyrrolidone / N-vinylimidazolium salts (Luviquat E Hold ), cationic cellulose derivatives (Polyquaternium-4 and -10), acrylamidocopolymers (Polyquaternium-7) and chitosan.
  • polyquaternium with the designation polyquaternium according to INCI, for example cop
  • Suitable cationic (quaternized) polymers are also Merquat (polymer based on dimethyldiallylammonium chloride), gafquat (quaternary polymers which are formed by reaction of polyvinylpyrrolidone with quaternary ammonium compounds), polymer JR (hydroxyethylcellulose with cationic groups) and plant-based cationic polymers, eg Guarpolymers, such as the Jaguar brands of Rhodia.
  • polystyrene resins are also neutral polymers, such as polyvinylpyrrolidones, copolymers of N-vinylpyrrolidone and vinyl acetate and / or vinyl propionate, polysiloxanes, polyvinylcaprolactam and other copolymers with N-vinylpyrrolidone, polyethylenimines and their salts, polyvinylamines and their salts, cellulose derivatives, Polyasparaginic acid salts and derivatives.
  • neutral polymers such as polyvinylpyrrolidones, copolymers of N-vinylpyrrolidone and vinyl acetate and / or vinyl propionate, polysiloxanes, polyvinylcaprolactam and other copolymers with N-vinylpyrrolidone, polyethylenimines and their salts, polyvinylamines and their salts, cellulose derivatives, Polyasparaginic acid salts and derivatives.
  • Suitable polymers are also nonionic, water-soluble or water-dispersible polymers or oligomers, such as polyvinylcaprolactam, e.g. Luviskol 0 Plus (BASF), or polyvinylpyrrolidone and their copolymers, in particular with vinyl esters, such as vinyl acetate, e.g. Luviskol 0 VA 37 (BASF), polyamides, e.g. based on itaconic acid and aliphatic diamines, e.g. in DE-A-43 33 238 are described.
  • polyvinylcaprolactam e.g. Luviskol 0 Plus (BASF)
  • BASF Luviskol 0 VA 37
  • polyamides e.g. based on itaconic acid and aliphatic diamines, e.g. in DE-A-43 33 238 are described.
  • Suitable polymers are also amphoteric or zwitterionic polymers, such as those available under the names Amphomer (National Starch) octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate hydroxypropyl methacrylate copolymers and zwitterionic polymers, as described for example in German patent applications DE39 29 973, DE 21 50 557, DE 28 17 369 and DE 3708 451 are disclosed. Acrylamidopropyl trimethylammonium chloride / acrylic acid or. Methacrylic acid copolymers and their alkali metal and ammonium salts are preferred zwitterionic polymers.
  • zwitterionic polymers are methacroylethylbetaine / methacrylate copolymers, which are commercially available under the name Amersette (AMERCHOL), and copolymers of hydroxyethyl methacrylate, methyl methacrylate, N, N-dimethylaminoethyl methacrylate and acrylic acid (Jordapon (D)).
  • Suitable polymers are also nonionic, siloxane-containing, water-soluble or -dispersible polymers, for example polyether siloxanes, such as Tegopren 0 (Goldschmidt) or Besi & commat (Wacker).
  • polyether siloxanes such as Tegopren 0 (Goldschmidt) or Besi & commat (Wacker).
  • the use of the molecularly imprinted polymers in combination with the dermocosmetic active substances is also advantageously selected from the group consisting of acetylsalicylic acid, atropine, azulen len, hydrocortisone and its derivatives, for.
  • vitamins of the B and D series especially vitamin Bi, vitamin B12, vitamin D, vitamin A or its derivatives such as retinyl palmitate, vitamin E or its derivatives such as tocopheryl acetate, vitamin C and its Derivatives such as ascorbyl glucoside but also niacinamide, panthenol, bisabolol, polydocanol, unsaturated fatty acids, such as the essential fatty acids (commonly referred to as vitamin F), in particular the ⁇ -linolenic acid, oleic acid, eicosapentaenoic acid, docosahexaenoic acid and derivatives thereof, ChIo - ramphenicol, caffeine, prostaglandins, thymol, camphor, squalene, extracts or other products of plant and animal origin, e.g.
  • the active compound or agents are furthermore advantageously selected from the group of NO synthase inhibitors, in particular when the preparations according to the invention are used for the treatment and prophylaxis of the symptoms of intrinsic and / or extrinsic skin aging and for the treatment and prophylaxis of the harmful effects of ultraviolet radiation on the skin and the Hair should serve.
  • Preferred NO synthase inhibitor is nitroarginine.
  • the active ingredient (s) are selected from the group comprising catechins and bile acid esters of catechins and aqueous or organic extracts from plants or plant parts which have a content of catechins or bile acid esters of catechins, such as the leaves of the plant family Theaceae, in particular of the species Camellia sinsis (green tea).
  • catechins and bile acid esters of catechins are selected from the group comprising catechins and bile acid esters of catechins and aqueous or organic extracts from plants or plant parts which have a content of catechins or bile acid esters of catechins, such as the leaves of the plant family Theaceae, in particular of the species Camellia sinsis (green tea).
  • Particularly advantageous are their typical ingredients (eg polyphenols or catechins, caffeine, vitamins, sugars, minerals, amino acids, lipids).
  • Catechins represent a group of compounds which are to be regarded as hydrogenated flavones or anthocyanidins and derivatives of "catechin” (catechol, 3, 3 ', 4', 5,7-flavanpentaol, 2- (3,4-dihydroxyphenyl) -chroman
  • epicate-chin ((2R, 3R) -3,3 ', 4', 5,7-flavanpentaol) is an advantageous active ingredient in the context of the present invention
  • Extracts containing catechins in particular extracts of green tea, such as extracts from leaves of the plants of the species Camellia spec., In particular the teas Camellia sinensis, C. assamica, C. taliensis and C.
  • active substances are furthermore polyphenols or catechins from the group (-) - catechin, (+) - catechin, (-) - catechin gallate, (-) - Gallocatechin gallate, (+) - epicatechin, (-) - epicatechin, (-) - epicatechin gallate, (-) - epigallocatechin, (-) - epigallocatechin gallate.
  • flavone and its derivatives are advantageous active ingredients in the sense of the present invention and are characterized by the following basic structure (substitution positions indicated):
  • flavones usually occur in glycosidated form.
  • the flavonoids are preferably selected from the group of substances of the general formula
  • Zi to Z 7 independently of one another, are selected from the group consisting of H, OH, alkoxy and hydroxyalkoxy, where the alkoxy or hydroxyalkoxy groups can be branched and unbranched and can have 1 to 18 C atoms, and where GIy is selected is selected from the group of mono- and oligoglycoside radicals.
  • the active ingredients can also be chosen very advantageously from the group of hydrophilic active ingredients, in particular from the following group: ⁇ -hydroxy acids such as lactic acid or salicylic acid or salts thereof, such as. Na lactate, Ca lactate, TEA lactate, urea, allantoin, serine, sorbitol, glycerin, milk proteins, panthenol, chitosan.
  • ⁇ -hydroxy acids such as lactic acid or salicylic acid or salts thereof, such as. Na lactate, Ca lactate, TEA lactate, urea, allantoin, serine, sorbitol, glycerin, milk proteins, panthenol, chitosan.
  • the amount of such active ingredients (one or more compounds) in the preparations according to the invention is preferably 0.001 to 30 wt .-%, particularly preferably 0.05 to 20 wt .-%, in particular 1 to 10 wt .-%, based on the Total weight of the preparation.
  • the above-mentioned and other active substances which can be used in the preparations according to the invention are specified in DE 103 18 526 A1 on pages 12 to 17, to which reference is made at this point in its entirety.
  • the present invention relates to the use of the o.g. Preparations for the prevention of unwanted changes in the appearance of the skin, e.g. Acne or oily skin, keratoses, rosaceae, photosensitive, inflammatory, erythematous, allergic or autoimmune reactive reactions.
  • compositions according to the invention are preferably skin protection agents, skin care agents, skin cleansing agents, hair protection agents, hair care preparations, hair cleaners, hair dyes, mouthwashes and mouthwashes, or preparations for decorative cosmetics, preferably in the form of ointments, creams, emulsions, suspensions, depending on the field of application. Lotions, as milk, pastes, gels, foams or sprays are applied.
  • the dermocosmetics according to the invention may contain, in addition to the active-molecular-imprinted polymers according to the invention or prepared by the inventive process, all the polymers already mentioned above, pigments, humectants, oils, waxes, enzymes, minerals, vitamins, sunscreens, dyes, fragrances, Antioxidants, preservatives and / or pharmaceutical agents.
  • the formulation base of agents according to the invention preferably contains cosmetically or dermocosmetically / pharmaceutically acceptable excipients.
  • Pharmaceutically acceptable excipients which are known to be useful in the pharmaceutical, food technology and related fields, in particular those listed in relevant pharmacopoeias (eg DAB Ph. Eur. BP NF) and other excipients whose properties do not preclude physiological application.
  • Suitable auxiliaries may be: lubricants, wetting agents, emulsifying and suspending agents, preserving agents, antioxidants, anti-irritants, chelating agents, emulsion stabilizers, film formers, gelling agents, odor masking agents, resins, hydrocolloids, solvents, solubilizers, neutralizing agents, permeation accelerators, pigments, quaternary ammonium compounds, Refatting and overfatting agents, ointment, cream or oil bases, silicone derivatives, stabilizers, sterilants, blowing agents, drying agents, opacifiers, thickeners, waxes, softeners, white oil.
  • a related embodiment is based on expert knowledge, as shown for example in Fiedler, H. P. Lexicon of excipients for pharmacy, cosmetics and related fields, 4th ed., Aulendorf: ECV Editio-Kantor-Verlag, 1996.
  • the active substances can be mixed or diluted with a suitable excipient (excipient).
  • excipients may be solid, semi-solid or liquid materials which may serve as a vehicle, carrier or medium for the active ingredient.
  • the admixing of further auxiliaries takes place in the manner known to the person skilled in the art.
  • the polymers and dispersions are suitable as auxiliaries in pharmacy, preferably as or in coating agent (s) or binder (s) for solid dosage forms. They can also be used in creams and as tablet coatings and tablet binders.
  • the agents according to the invention are cosmetic agents for the care and protection of the skin and hair, nail care preparations or preparations for decorative cosmetics.
  • Suitable skin-cosmetic agents are, for example, face lotions, face masks, deodorizers and other cosmetic lotions.
  • Means for use in decorative cosmetics include, for example, masking pens, theatrical paints, mascara and eye shadows, lipsticks, kohl pencils, eyeliners, rouges, powders, and eyebrow pencils.
  • the molecularly imprinted polymers can be used in nasal strips for pore cleansing, anti-acne agents, repellents, shaving agents, after- and pre-shave care products, after-sun care products, hair-removing agents, hair dyes, personal hygiene products, foot care products and baby care.
  • the skin care agents according to the invention are in particular VWO or O / W skin creams, day and night creams, eye creams, face creams, anti-wrinkle creams, sunscreen creams, moisturizing creams, bleaching creams, self-tanning creams, vitamin creams, skin lotions, skin lotions and moisturizing lotions.
  • Skin-cosmetic and dermatological compositions according to the invention may further contain, as protection against oxidative processes and the associated aging processes or damage to the skin and / or hair, in addition to the active ingredient-molecular-imprinted polymers prepared according to the invention or according to the inventive process, a radical-decomposing active ingredient.
  • active substances are preferably the substances described in the patent applications WO / 0207698 and WO / 03059312, the contents of which are hereby incorporated by reference, preferably the boron-containing compounds described there, the peroxides or hydroperoxides to give the corresponding alcohols without formation reduce radical development.
  • sterically hindered amines according to the general formula can be used for this purpose,
  • radical Z has the following meaning: H, C1-C22 alkyl group, preferably C1-C12 alkyl group such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec. butyl, tert. Butyl, pentyl, isopentyl, neopentyl, tert.
  • alkoxy-pentyl alkoxy-isopentyl, alkoxy-neopentyl, alkoxy-tert.
  • Pentyl alkoxy-hexyl, alkoxy-heptyl, alkoxy-octyl, alkoxy-nonyl, alkoxy-decyl, alkoxy-undecyl, Al koxy-dodecyl, C6 to C10-aryl group such as phenyl and naphthyl, where the phenyl radical having C1 to C4 alkyl C6 to C10-O-aryl group which may be substituted by a C1-C22 alkyl or C1-C22 alkoxyl group, preferably with a C1-C12 alkyl or C1-C12 alkoxyl group as described above ,
  • sterically hindered amines 3-dodecyl-N- (2,2,6,6-tetramethyl-4-piperidinyl) succinimide, 3-dodecyl-N- (1, 2,2,6, 6-penta -methyl-4-piperidinyl) succinimide, 3-octyl-N- (2,2,6,6-tetramethyl-4-piperidinyl) succinimide, 3-octyl-N- (1, 2,2,6,6-pentamethyl 4-piperidinyl) succinimide, 3-octenyl-N- (2,2,6,6-tetramethyl-4-piperidinyl) succinimide, 3-octenyl-N- (1, 2,2,6,6-pentamethyl-4 -piperidinyl) succinimide and / or Uvinul®5050H, in a proportion of 0.001 to 1 weight percent (wt .-%), preferably 0.01 to 0.1 w
  • the skin cosmetic preparations may contain, in addition to the abovementioned compounds of the invention and suitable carriers, other active ingredients and adjuvants customary in skin cosmetics, as described above. These preferably include emulsifiers, preservatives, perfume oils, cosmetic active ingredients such as phytantriol, vitamins A, E and C, retinol, bisabolol, panthenol, light stabilizers, bleaching agents, colorants, tinting agents, tanning agents, collagen, protein hydrolysates, stabilizers, pH regulators , Dyes, salts, thickeners, gelling agents, bodying agents, silicones, humectants, moisturizers and / or other customary additives.
  • emulsifiers emulsifiers, preservatives, perfume oils, cosmetic active ingredients such as phytantriol, vitamins A, E and C, retinol, bisabolol, panthenol, light stabilizers, bleaching agents, colorants, tinting agents, tanning agents,
  • Preferred oil and fat components of the dermocosmetic and dermocosmetic agents are the aforementioned mineral and synthetic oils, such as paraffins, silicone oils and aliphatic hydrocarbons having more than 8 carbon atoms, animal and vegetable oils, such as sunflower oil, coconut oil, avocado oil, olive oil, lanolin, or waxes, fatty acids, fatty acid esters such as triglycerides of C6-C30 fatty acids, wax esters such as jojoba oil, fatty alcohols, petrolatum, hydrogenated lanolin and acetylated lanolin, and mixtures thereof.
  • mineral and synthetic oils such as paraffins, silicone oils and aliphatic hydrocarbons having more than 8 carbon atoms
  • animal and vegetable oils such as sunflower oil, coconut oil, avocado oil, olive oil, lanolin, or waxes
  • fatty acids such as triglycerides of C6-C30 fatty acids
  • wax esters such as jojoba oil
  • fatty alcohols such as petrolatum
  • the skin-cosmetic and dermocosmetic preparations may additionally also contain conditioning substances based on silicone compounds.
  • Suitable silicone compounds are, for example, polyalkylsiloxanes, polyarylsiloxanes, polyarylalkylsiloxanes, polyethersiloxanes or silicone resins.
  • the preparation of the cosmetic or dermocosmetic preparations is carried out by customary methods known to the person skilled in the art.
  • the cosmetic and dermocosmetic agents are preferably in the form of emulsions, in particular as water-in-oil (W / O) or oil-in-water (O / W) emulsions.
  • formulations for example, gels, oils, oleogels, multiple emulsions, for example in the form of W / O / W or O7W / O emulsions, anhydrous ointments or ointment bases, etc.
  • emulsifier-free formulations such as hydrodispersions, hydrogels or a Pickering emulsion are advantageous embodiments.
  • Emulsions are prepared by known methods.
  • the emulsions generally contain conventional constituents, such as fatty alcohols, fatty acid esters and especially fatty acid triglycerides, fatty acids, lanolin and derivatives thereof, natural or synthetic oils or waxes and emulsifiers in the presence of water.
  • a suitable emulsion as W / O emulsion e.g. for a skin cream, etc., generally contains an aqueous phase which is emulsified by means of a suitable emulsifier system in an oil or fat phase.
  • a polyelectrolyte complex can be used.
  • Preferred fat components which may be included in the fat phase of the emulsions are: hydrocarbon oils such as paraffin oil, purcellin oil, perhydrosqualene and solutions of microcrystalline waxes in these oils; animal or vegetable oils, such as sweet almond oil, avocado oil, calophilum oil, lanolin and derivatives thereof, castor oil, seed oil, olive oil, jojoba oil, karite oil, hoplostethus oil, mineral oils whose distillates Beginning under atmospheric pressure at about 250 0 C and its distillation end point at 410 0 C, such as Vaselineöl, esters of saturated or unsaturated fatty acids, such as alkyl myristates, for example i-propyl, butyl or Cetylmyristat, hexadecyl, ethyl or i-Propylpalmitat , Octanoic or Decankladriglyceride and Cetylricinoleat.
  • hydrocarbon oils such as paraffin oil, purcellin oil
  • the fat phase may also contain other oil-soluble silicone oils such as dimethylpolysiloxane, methylphenylpolysiloxane and the silicone glycol copolymer, fatty acids and fatty alcohols.
  • oil-soluble silicone oils such as dimethylpolysiloxane, methylphenylpolysiloxane and the silicone glycol copolymer, fatty acids and fatty alcohols.
  • the skin care agents may also contain waxes, e.g. Carnauba wax, candililla wax, beeswax, microcrystalline wax, ozokerite wax and Ca, Mg and Al oleates, myristates, linoleates and stearates.
  • waxes e.g. Carnauba wax, candililla wax, beeswax, microcrystalline wax, ozokerite wax and Ca, Mg and Al oleates, myristates, linoleates and stearates.
  • an emulsion of the invention may be present as O / W emulsion.
  • Such an emulsion usually contains an oil phase, emulsifiers that stabilize the oil phase in the water phase, and an aqueous phase that is usually thickened.
  • Suitable emulsifiers are preferably O / W emulsifiers, such as polyglycerol esters, sorbitan esters or partially esterified glycerides into consideration.
  • the agents according to the invention are a light stabilizer, a shower gel, a shampoo formulation or a bath preparation, sunscreen preparations being particularly preferred.
  • Such formulations comprise at least one of the present invention or produced according to the inventive process drug-molecularly imprinted polymers and usually anionic surfactants as base surfactants and amphoteric and / or nonionic surfactants as cosurfactants.
  • suitable active ingredients and / or adjuvants are generally selected from lipids, perfume oils, dyes, organic acids, preservatives and antioxidants and thickeners / gelling agents, skin conditioners and moisturizers.
  • formulations preferably contain from 2 to 50% by weight, preferably from 5 to 40% by weight, particularly preferably from 8 to 30% by weight, of surfactants, based on the total weight of the formulation.
  • Suitable anionic surfactants are, for example, alkyl sulfates, alkyl ether sulfates, alkyl sulfonates, alkylaryl sulfonates, alkyl succinates, alkyl sulfosuccinates, N-alkoyl sarcosyls. nate, acyl taurates, acyl isothionates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates, alpha olefin sulfonates, especially the alkali and alkaline earth metal salts, for example sodium, potassium, magnesium, calcium, and ammonium and triethanolamine salts.
  • the alkyl ether sulfates, alkyl ether phosphates and alkyl ether carboxylates can have between 1 to 10 ethylene oxide or propylene oxide units, preferably 1 to 3 ethylene oxide units in the molecule.
  • Suitable amphoteric surfactants are e.g. Alkylbetaines, alkylamidopropylbetaines, alkylsulfobetaines, alkylglycinates, alkylcarboxyglycinates, alkylamphoacetates or -propionates, alkylamphodiacetates or -dipropionates.
  • cocodimethylsulfopropyl betaine cocodimethylsulfopropyl betaine, lauryl betaine, cocamidopropyl betaine or sodium cocamphopropionate can be used.
  • Suitable nonionic surfactants are, for example, the reaction products of aliphatic alcohols or alkylphenols having 6 to 20 C atoms in the alkyl chain, which may be linear or branched, with ethylene oxide and / or propylene oxide.
  • the amount of alkylene oxide is about 6 to 60 moles per mole of alcohol.
  • alkylamine oxides, mono- or dialkylalkanolamides, fatty acid esters of polyethylene glycols, ethoxylated fatty acid amides, alkylpolyglycosides or sorbitan ether esters are also suitable.
  • washing, showering and bathing preparations may contain conventional cationic surfactants, e.g. quaternary ammonium compounds, for example cetyltrimethylammonium chloride.
  • conventional cationic surfactants e.g. quaternary ammonium compounds, for example cetyltrimethylammonium chloride.
  • shower gel / shampoo formulations may contain thickeners, e.g. Common salt, PEG-55, propylene glycol oleate, PEG-120 methyl glucose dioleate and others, as well as preservatives, other active ingredients and auxiliaries and water.
  • thickeners e.g. Common salt, PEG-55, propylene glycol oleate, PEG-120 methyl glucose dioleate and others, as well as preservatives, other active ingredients and auxiliaries and water.
  • the dermocosmetics according to the invention are hair treatment agents.
  • the hair treatment compositions according to the invention are in the form of a mousse, hair mousse, hair gel, shampoos, hair sprays, hair mousse, top fluids, leveling agents, hair dyeing and bleaching or "Hot oil treatments" before.
  • the hair cosmetic preparations can be applied as (aerosol) spray, (aerosol) foam, gel, gel spray, cream, lotion or wax.
  • Hairsprays include both aerosol sprays and pump sprays without propellant gas.
  • Hair foams include both aerosol foams and pump foams without propellant gas.
  • Hair sprays and hair foams preferably comprise predominantly or exclusively water-soluble or water-dispersible components.
  • the compounds used in the hair sprays and hair foams according to the invention are water-dispersible, they can be used in the form of aqueous microdispersions with particle diameters of usually from 1 to 350 nm, preferably from 1 to 250 nm.
  • the solids contents of these preparations are usually in a range of about 0.5 to 20 wt .-%.
  • these microdispersions do not require emulsifiers or surfactants for their stabilization.
  • ingredients are understood to include the additives customary in cosmetics, for example propellants, defoamers, surface-active compounds, i. Surfactants, emulsifiers, foaming agents and solubilizers.
  • the surface-active compounds used can be anionic, cationic, amphoteric or neutral.
  • Other common ingredients may also be e.g. Preservatives, perfume oils, opacifiers, active ingredients, UV filters, care ingredients such as panthenol, collagen, vitamins, protein hydrolysates, alpha and beta hydroxycarboxylic acids, stabilizers, pH regulators, dyes, viscosity regulators, gel formers, salts, humectants, moisturizers, complexing agents and other common additives.
  • this includes all known in cosmetics styling and conditioner polymers that can be used in combination with the molecularly imprinted polymers, if very special properties are to be set.
  • Suitable conventional hair cosmetic polymers are the abovementioned cationic, anionic, neutral, nonionic and amphoteric polymers, to which reference is hereby made.
  • the preparations may additionally contain conditioning substances based on silicone compounds.
  • Suitable silicone compounds are, for example, polyalkylsiloxanes, polyarylsiloxanes, polyarylalkylsiloxanes, polyethersiloxanes, silicone resins or dimethicone copolyols (CTFA) and amino-functional silicone compounds such as amodimethicones (CTFA).
  • Blowing agents are the blowing agents commonly used for hairsprays or aerosol foams. Preference is given to mixtures of propane / butane, pentane, dimethyl ether, 1,1-difluoroethane (HFC-152a), carbon dioxide, nitrogen or compressed air.
  • emulsifiers all emulsifiers commonly used in hair foams can be used. Suitable emulsifiers may be nonionic, cationic or anionic or amphoteric.
  • nonionic emulsifiers are Laurethe, for example Laureth-4; Cetethees, for example cetheth-1, polyethylene glycol cetyl ethers, cetearethes, for example cetheareth-25, polyglycol fatty acid glycerides, hydroxylated lecithin, lactyl esters of fatty acids, alkylpolyglycosides.
  • cationic emulsifiers are cetyldimethyl-2-hydroxyethylammonium dihydrogenphosphate, cetyltrimonium chloride, cetyltrimmonium bromide, cocotrimonium methylsulfate, quaternium-1 to x (INCI).
  • Anionic emulsifiers may, for example, be selected from the group of alkyl sulfates, alkyl ether sulfates, alkyl sulfonates, alkylaryl sulfonates, alkyl succinates, alkyl sulfosuccinates, N-alkoyl sarcosinates, acyl taurates, acyl isethionates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates, alpha olefin sulfonates, especially the alkali and alkaline earth metal salts, e.g.
  • alkyl ether sulfates, alkyl ether phosphates and alkyl ether carboxylates can have between 1 to 10 ethylene oxide or propylene oxide units, preferably 1 to 3 ethylene oxide units in the molecule.
  • gel formers all gel formers customary in cosmetics can be used. These include lightly crosslinked polyacrylic acid, for example carbomer (INCI), celulose derivatives, e.g. Hydroxypropyl cellulose, hydroxyethyl cellulose, cationic modified celluloses, polysaccharides, e.g.
  • Xanthan gum caprylic / capric triglyceride, sodium acrylate copolymers
  • Suitable anionic surfactants are, for example, alkyl sulfates, alkyl ether sulfates, alkyl sulfonates, alkylaryl sulfonates, alkyl succinates, alkyl sulfosuccinates, N-alkoxy sarcosinates, acyl taurates, acyl isothionates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates, alpha-olefin sulfonates, in particular the alkali and alkaline earth metal salts, for example sodium, potassium, magnesium, calcium , as well as ammonium and triethanolamine salts.
  • alkali and alkaline earth metal salts for example sodium, potassium, magnesium, calcium , as well as ammonium and triethanolamine salts.
  • the alkyl ether sulfates, alkyl ether phosphates and alkyl ether carboxylates can have between 1 to 10 ethylene oxide or propylene oxide units, preferably 1 to 3 ethylene oxide units in the molecule.
  • Suitable examples are sodium lauryl sulfate, ammonium lauryl sulfate, sodium lauryl sulfate, ammonium lauryl ether sulfate, sodium lauroyl sarcosinate, sodium oleyl succinate, ammonium lauryl sulfosuccinate, sodium dodecylbenzenesulfonate, triethanolamine dodecylbenzenesulfonate.
  • Suitable amphoteric surfactants are, for example, alkylbetaines, alkylamidopropylbetaines, alkylsulfobetaines, alkylglycinates, alkylcarboxyglycinates, alkylamphoacetates or -propionates, alkylamphodiacetates or -dipropionates.
  • cocodimethylsulfopropyl betaine cocodimethylsulfopropyl betaine, lauryl betaine, cocamidopropyl betaine or sodium cocamphopropionate can be used.
  • Suitable nonionic surfactants are, for example, the reaction products of aliphatic alcohols or alkylphenols having 6 to 20 C atoms in the alkyl chain, which may be linear or branched, with ethylene oxide and / or propylene oxide.
  • the amount of alkylene oxide is about 6 to 60 moles per mole of alcohol.
  • alkylamine oxides, mono- or dialkylalkanolamides, fatty acid esters of polyethylene glycols, alkylpolyglycosides or sorbitan ether esters are also suitable.
  • the shampoo formulations may contain conventional cationic surfactants, e.g. quaternary ammonium compounds, for example cetyltrimethylammonium chloride.
  • conventional cationic surfactants e.g. quaternary ammonium compounds, for example cetyltrimethylammonium chloride.
  • Conventional conditioning agents in combination with the molecularly imprinted polymer can be used in the shampoo formulations to achieve specific effects.
  • cationic polymers with the name Polyquaternium according to INCI, in particular copolymers of vinylpyrrolidone / N-vinylimidazolium salts (Luviquat FC, Luviquat & commat, HM, Luviquat MS, Luviquat Care), copolymers of N-vinylpyrrolidone / dimethylaminoethyl methacrylate, quaternized with diethyl sulfate ( Luviquat D PQ 1 1), copolymers of N-vinylcaprolactam / N-vinylpyrrolidone / N-vinylimidazolium salts (Luviquat D Hold), cationic cellulose derivatives (Polyquaternium-4 and -10), acrylamide copolymers (Polyquaternium-7).
  • protein hydrolysates can be used, as well as conditioning substances based on silicone compounds, for example polyalkylsiloxanes, polyarylsiloxanes, polyarylalkylsiloxanes, polyethersiloxanes or silicone resins.
  • silicone compounds for example polyalkylsiloxanes, polyarylsiloxanes, polyarylalkylsiloxanes, polyethersiloxanes or silicone resins.
  • suitable silicone compounds are dimethicone copolyols (CTFA) and amino-functional silicone compounds such as amodimethicones (CTFA).
  • CTFA dimethicone copolyols
  • amino-functional silicone compounds such as amodimethicones
  • cationic guar derivatives such as guar hydroxypropyltrimonium chloride (INCI) can be used.
  • this hair cosmetic or skin cosmetic preparation is for the care or protection of the skin or hair and is in the form of an emulsion, a dispersion, a suspension, an aqueous surfactant preparation, a milk, a lotion, a cream, a balm, an ointment, gel, granule, powder, stick preparation, such as a lipstick, foam, aerosol or spray.
  • emulsions are oil-in-water emulsions and water-in-oil emulsions or microemulsions.
  • the hair cosmetic or skin cosmetic preparation is used for application on the skin (topically) or hair.
  • Topical preparations are to be understood as meaning those preparations which are suitable for applying the active ingredients to the skin in fine distribution and preferably in a form absorbable by the skin.
  • aqueous and aqueous-alcoholic solutions sprays, foams, foam aerosols, ointments, aqueous gels, emulsions of the O7W or W / O type, microemulsions or cosmetic stick preparations.
  • the agent contains a carrier.
  • a carrier is water, a gas, a water-based liquid, an oil, a gel, an emulsion or microemulsion, a dispersion or a mixture thereof.
  • the mentioned carriers show good skin tolerance.
  • Particularly advantageous for topical preparations are aqueous gels, emulsions or microemulsions.
  • Nonionic surfactants, zwitterionic surfactants, ampholytic surfactants or anionic emulsifiers can be used as emulsifiers.
  • the emulsifiers may be present in the composition according to the invention in amounts of 0.1 to 10, preferably 1 to 5 wt .-%, based on the composition.
  • a surfactant of at least one of the following groups may be used:
  • Partial esters based on linear, branched, unsaturated or saturated C6 / 22 fatty acids, ricinoleic acid and 12-hydroxystearic acid and glycerol, polyglycerol, pentaerythritol, dipentaerythritol, sugar alcohols (eg sorbitol), alkyl glucosides (eg methyl glucoside, butyl glucoside , Lauryl glucoside) as well as polyglucosides (eg cellulose); Mono-, di- and trialkyl phosphates and mono-, di- and / or tri-PEG-alkyl phosphates and their salts;
  • Polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives Polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives; Mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol according to DE PS 1165574 and / or mixed esters of fatty acids having 6 to 22 carbon atoms, methyl glucose and polyols, preferably glycerol or polyglycerol and polyalkylene glycols.
  • zwitterionic surfactants can be used as emulsifiers.
  • Zwitterionic surfactants are those surface-active compounds which carry at least one quaternary ammonium group and at least one carboxy or sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines, such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylamino-propyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkylbenzenesulfonate.
  • 3-carboxymethyl-3-hydroxy-ethylimidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethyl carboxymethylglycinate.
  • Particularly preferred is the fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine.
  • ampholytic surfactants are to be understood as meaning those surface-active compounds which, apart from a C 8, 18 alkyl or acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO 2 H group and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylamino-butanoic acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamido-propylglycines, N-alkyltaurines, N alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 18 C atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12/18 acylsarcosine.
  • Quaternary emulsifiers are also suitable in addition to the ampholytic ones, those of the esterquat type, preferably methyl-quaternized difatty acid triethanolamine ester salts, being particularly preferred. It is also possible to use, as anionic emulsifiers, alkyl ether sulfates, monoglyceride sulfates, fatty acid sulfates, sulfosuccinates and / or ether carboxylic acids.
  • Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10, carbon atoms, esters of linear C6-C22 fatty acids with linear C6-C22 fatty alcohols, esters of branched C6-C13 carboxylic acids with linear Ce- C22 Fatty alcohols, esters of C6-C22 linear fatty acids with branched alcohols, in particular 2-ethylhexanol, esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimerdiol or trimer triol) and / or Guerbet alcohols, triglycerides based on C6- Cio-fatty acids, liquid mono- / di-, Trigly- ceridmischept based on C ⁇ -Ci ⁇ -fatty acids, esters of C6-C22 fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, in particular benzoic acid, esters of C2-Ci2-dica
  • oils bodies are silicone compounds, for example dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and also amino, fatty acid, alcohol, polyether, epoxy, fluorine, alkyl and / or glycoside-modified silicone compounds which may be both liquid and resinous at room temperature.
  • the oil bodies may be present in the compositions according to the invention in amounts of from 1 to 90, preferably from 5 to 80, and in particular from 10 to 50,% by weight, based on the composition.
  • a 2-liter HWS reactor was equipped with a condenser, a stirrer motor, an anchor stirrer, a glass fritted nitrogen inlet tube, a Julabo LC 3 laboratory controller with 2 PT-100 thermosensors, an oil bath with immersion heater and magnetic stirrer, and 2 HPLC Pumps (Bischoff) each equipped with a pump head (0-1 mL / min) for dosing initiator and monomers.
  • the apparatus was purged with nitrogen before the start of the experiment. During the entire experiment, nitrogen was passed through the solution at a flow rate of about 10 L / h.
  • the template in the reactor was heated with stirring to 75 0 C and again taken a sample 1 mL.
  • solution 2 Another solution (solution 2) was prepared by dissolving the remaining 3/4 of the initiator, corresponding to 1.594 g, in 250 ml of acetonitrile. The second half of solution 1 and solution 2 were added by means of the two HPLC pumps in the reactor over a period of 18 h. The metering rates for solution 1 were 0.153 ml / min, and for solution 2: 0.232 ml / min.
  • the subsequent post-reaction time was 6 hours, so the total reaction time thus 24 h.
  • a 1 mL sample was taken from the reaction mixture and, after filtration, subjected to HPLC analysis.
  • the polymer suspension was taken out of the reactor and filtered using a suction filter. The filter cake was washed three times with 100 ml of acetonitrile and dried at 50 0 C in a vacuum.
  • Example b A 2-liter HWS reactor was equipped with a condenser, a stirrer motor, an anchor stirrer, a glass fritted nitrogen inlet tube, a Julabo LC 3 laboratory controller with 2 PT-100 thermosensors, an oil bath with immersion heater and magnetic stirrer. The apparatus was purged with nitrogen before the start of the experiment. Nitrogen was used throughout the experiment with a volume flow of about 10 L / h passed through the solution. 1000 ml of solvent acetonitrile (AcN) were introduced into the reaction vessel and dissolved in this 17.25 g of ⁇ -tocopherol (template), 6.12 g of methacrylic acid and 76.32 g of trimethylolpropane trimethacrylate.
  • AcN solvent acetonitrile
  • a 500 mL round bottom flask was equipped with a Soxhlet apparatus, a condenser, a magnetic stirrer and a laboratory controller (Julabo LC 3 with 2 PT 100) and immersed in an oil bath.
  • 8 g of polymer were extracted with 400 ml of methanol / glacial acetic acid (7: 1, v / v) (EXTRACT 1) for 6-8 hours and then 6 hours with 400 ml of methanol (EXTRACT 2) in the Soxhlet apparatus.
  • the extracts were collected, their volume determined and each stored a 2 ml sample for ⁇ -tocopherol concentration determination by HPLC in the refrigerator at 4 0 C.
  • Example 3 Loading the polymer with a cosmetic active ingredient
  • a Millipore ultrafiltration cell (model 8400) was connected to a 5 liter plastic canister as a storage vessel (contents: water).
  • the cell was filled with a dispersion of 100 mg of polymer in 100 ml of water and stirred for 15 minutes until homogenization with the magnetic stirrer installed in the ultrafiltration cell.
  • the extractant (water) was passed via the inlet without overpressure from the storage vessel into the cell.
  • the extract emerging from the cell was at the bottom of the Cell is led into a collecting vessel.
  • the volume, mass and time of each fraction were determined and each sample was sampled 2 ml.
  • Several fractions were collected over the experimental period. These samples were filtered through a 0.45 ⁇ l filter and stored in the refrigerator at 4 ° C. for the ⁇ -tocopherol concentration determination by HPLC.
  • the dispersion was removed from the ultrafiltration vessel and bottled after the end of the experiment.
  • FIG. 1 Controlled release of DL-alpha-tocopherol from loaded trimethylolpropane trimethacrylate MIP particles - Continuous extraction of the DL-alpha-tocopherol from the polymers with water of different pH values in ultrafiltration cells - Plot of the absolute cumulative released DL-alpha Tocopherol masses against time.
  • FIG. 2 Controlled release of DL-alpha-tocopherol from loaded methacrylic acid-trimethylolpropane trimethacrylate MIP particles - Extraction of the DL-alpha-tocopherol from the polymers with water of different pH values in batch reactors - Application of DL-alpha-tocopherol Concentrations in the batch reactor against time.
  • FIG. 3 Controlled release of trichloroisocyanuric acid from methacrylic acid trimethylolpropane trimethacrylate MIP particles - Continuous extraction of the trichloroisocyanuric acid from the polymers with water of different pH values in ultrafiltration cells - Plot of the absolute cumulative liberated trichloroisocyanuric acid masses against time.
  • Desmocosmetic preparations according to the invention are described below, containing the molecularly imprinted polymer prepared according to Example 1 with ⁇ -tocopherol as template molecule.
  • Said molecularly imprinted polymer with ⁇ -tocopherol as a template molecule is referred to as MIP in the following examples.
  • the molecularly imprinted polymer with ⁇ -tocopherol as template molecule is mentioned in the following examples as representative of all other described molecularly imprinted polymers with active ingredient. It is obvious to the person skilled in the art that all other active substances mentioned can also be prepared according to Example 1 and used in the preparations mentioned below.
  • Example 8 Use of MIP in a Facial Cleansing Lotion - Type O / W WS 1%:
  • Example 9 Use of the MIP in a Daily Care Body Spray
  • Example 24 Styling foam WS 1%
  • Preparation Mix the components of phase A. Add the components of phase B one by one and dissolve. Phase C in the mixture of A and B dissolved then adjust the pH to 6-7. Fill with phase D.
  • Example 36 Liquid Make-up - Type O / W
  • Preparation Heat phases A and B separately to about 80 ° C. Stir phase B into phase A and homogenize. Cool with stirring to about 40 0 C, add phases C and D and thoroughly homogenize again. Allow to cool to room temperature while stirring.
  • Desmocosmetic preparations according to the invention are described below, containing the molecularly imprinted polymer prepared according to Example 1 with ⁇ -tocopherol as template molecule.
  • Said molecularly imprinted polymer with ⁇ -tocopherol as a template molecule is referred to as MIP in the following examples.
  • the molecularly imprinted polymer with ⁇ -tocopherol as template molecule is mentioned in the following examples as representative of all other described molecularly imprinted polymers with active ingredient. It is obvious to the person skilled in the art that all other active substances mentioned can also be prepared according to Example 1 and used in the preparations mentioned below.
  • the mentioned molecularly imprinted polymer with active ingredient is used as a solid.
  • the following information is parts by weight.
  • formulations are cosmetic sunscreen preparations containing a combination of at least one inorganic pigment, preferably zinc oxide and / or titanium dioxide and organic UV-A and UV-B filters and the molecularly imprinted polymer prepared according to Example 1 with ⁇ -tocopherol as template - described.
  • Said molecularly imprinted polymer with ⁇ -tocopherol as a template molecule is referred to as MIP in the following examples.
  • the molecularly imprinted polymer with ⁇ -tocopherol as template molecule is mentioned in the following examples as representative of all other described molecularly imprinted polymers with active ingredient. It goes without saying for the expert that all the others too mentioned active ingredients prepared according to Example 1 and can be used in the preparations mentioned below.
  • the template molecule in the molecularly imprinted polymers is an organic UV filter which is released via the described release mechanism on the skin.
  • the content of molecularly imprinted polymer with active ingredient refers to 100%.
  • the inventive molecularly imprinted polymer can be used both in pure form and as an aqueous solution. In the case of the aqueous solution, the content of water must be the. be adapted in the respective formulation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP07803486A 2006-09-19 2007-09-14 Kosmetische zubereitungen auf basis molekular geprägter polymere Withdrawn EP2066406A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07803486A EP2066406A2 (de) 2006-09-19 2007-09-14 Kosmetische zubereitungen auf basis molekular geprägter polymere

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06120922 2006-09-19
EP07803486A EP2066406A2 (de) 2006-09-19 2007-09-14 Kosmetische zubereitungen auf basis molekular geprägter polymere
PCT/EP2007/059683 WO2008034764A2 (de) 2006-09-19 2007-09-14 Kosmetische zubereitungen auf basis molekular geprägter polymere

Publications (1)

Publication Number Publication Date
EP2066406A2 true EP2066406A2 (de) 2009-06-10

Family

ID=38996210

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07803486A Withdrawn EP2066406A2 (de) 2006-09-19 2007-09-14 Kosmetische zubereitungen auf basis molekular geprägter polymere

Country Status (8)

Country Link
US (2) US20100048737A1 (ja)
EP (1) EP2066406A2 (ja)
JP (1) JP2010503715A (ja)
KR (1) KR20090073170A (ja)
CN (1) CN101516448B (ja)
CA (1) CA2662911A1 (ja)
RU (1) RU2499607C2 (ja)
WO (1) WO2008034764A2 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102336871A (zh) * 2010-07-16 2012-02-01 中国科学院过程工程研究所 一种尺寸均一的氯霉素分子印迹聚合物微球及制备方法和应用

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102369223A (zh) * 2009-01-29 2012-03-07 国家科学和工业研究组织 分子印记聚合物
FR2952936B1 (fr) * 2009-11-26 2011-11-25 Flamel Tech Polymere de type acrylique ou methacrylique comprenant des greffons alpha-tocopherol
US8747817B1 (en) 2010-12-02 2014-06-10 William Scott Prendergast System and method of complementary day/night children's skin cream compositions
CN102380353B (zh) * 2011-09-19 2013-08-21 江苏大学 一种磁性氧化镁表面分子印迹固相萃取剂的制备方法
DE102011085497A1 (de) * 2011-10-31 2013-05-02 Evonik Industries Ag Kosmetische Formulierung
FR2997848B1 (fr) * 2012-11-09 2015-01-16 Oreal Composition comprenant un derive dicarbonyle et procede de lissage des cheveux a partir de cette composition
FR3000074B1 (fr) 2012-12-26 2015-01-16 Oreal Polymeres a empreinte moleculaire et leur utilisation comme agent antipelliculaire
FR2999920B1 (fr) * 2012-12-26 2015-07-17 Oreal Polymeres a empreinte moleculaire de type solgel et leur utilisation comme agent antipelliculaire
FR2999917B1 (fr) 2012-12-26 2017-06-23 Oreal Polymere a empreinte moleculaire pour pieger selectivement les molecules odorantes
FR2999918B1 (fr) 2012-12-26 2015-06-19 Oreal Polymere de type sol-gel a empreinte moleculaire pour pieger selectivement les molecules odorantes
CN103265665B (zh) * 2013-03-11 2016-03-09 新疆维吾尔自治区产品质量监督检验研究院 一种樟脑分子印迹聚合物及其整体柱和填充色谱柱的制备方法与应用
DE102013213170A1 (de) 2013-07-04 2015-01-08 Beiersdorf Ag Octocrylenfreies, geruchsstabiles Sonnenschutzmittel
DE102013018573A1 (de) * 2013-10-31 2015-05-21 Stephan Teichmann Oxidationsstabile Zubereitung
JP6645979B2 (ja) * 2014-03-07 2020-02-14 エンドーロジックス インコーポレイテッド ヒドロゲルを形成する改善された方法およびその材料
US9731151B2 (en) 2014-04-08 2017-08-15 Honeywell International Inc. Sprayable sunscreen compositions and methods
EP2957600A1 (en) * 2014-06-17 2015-12-23 Geneticlab S.r.l. Chemical mixture for the stabilization and conservation of organic material as nucleic acids and cells, and related stabilization method
CN104017126A (zh) * 2014-06-19 2014-09-03 天津科技大学 一种生育酚分子印迹荧光聚合物及制备方法和应用
DE102014213314A1 (de) 2014-07-09 2016-01-14 Henkel Ag & Co. Kgaa Neuartiges Waschverfahren
DE102014216602A1 (de) * 2014-08-21 2016-02-25 Beiersdorf Ag Stabile kosmetische Zubereitung
EP3037082A1 (en) * 2014-12-22 2016-06-29 Spirig Pharma AG Sprayable cosmetic sunscreen composition
EP3037083A1 (en) * 2014-12-22 2016-06-29 Spirig Pharma AG Emulsifier-free cosmetic sunscreen composition
WO2016106341A1 (en) * 2014-12-22 2016-06-30 H R D Corporation Small particle size renewable triglyceride waxes for use in consumer and industrial applications
BR112019010229B1 (pt) * 2017-04-28 2022-05-03 L'oreal Método para modelar os cabelos e uso de uma composição para cuidados com os cabelos em gel-creme
CN108283603A (zh) * 2018-04-02 2018-07-17 吴伟华 一种劳保护肤膏的制备方法
CN110511252A (zh) * 2019-08-05 2019-11-29 浙江李子园食品股份有限公司 一种微波-分子印迹聚合物联用提取纯化苹果多酚的方法
CN111205393B (zh) * 2020-03-06 2021-12-17 辽宁科技大学 用于吸附分离人参皂苷Rd的印迹聚合材料及制备方法
CN111359677B (zh) * 2020-03-13 2023-03-28 湖北文理学院 选择性降解邻苯二甲酸二丁酯的光电催化剂的制备方法
DE102020210312A1 (de) * 2020-08-13 2022-02-17 Beiersdorf Aktiengesellschaft Kosmetische Ethanol-in-Öl-Emulsion
CN112354524A (zh) * 2020-11-16 2021-02-12 榆林学院 分子印迹的壳聚糖/二氧化钛复合水凝胶及处理高浓度含酚废水的应用
RU2753515C1 (ru) * 2020-12-23 2021-08-17 Общество с ограниченной ответственностью «ШАРОВАПРО» (ООО «ШАРОВАПРО») Крем для лица
CN114524911B (zh) * 2022-01-20 2024-03-12 河南科技大学 一种葡聚糖内切印迹模拟酶、制备方法及其应用
CN114752099B (zh) * 2022-04-12 2023-04-07 佳木斯大学 磁性中空分子印迹聚合物及其在分离阿魏酸中的应用
FR3139720A1 (fr) * 2022-09-15 2024-03-22 Jean-Paul RIVET Composition cosmétique ou dermatologique utile pour la protection solaire ou le soin de la peau
CN116139833A (zh) * 2023-02-22 2023-05-23 南通大学 一种含铅废水处理剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237253A (en) * 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
CA1168157A (en) * 1981-03-23 1984-05-29 Eric S. Abrutyn Polymer entrapped emollient-moisturizer composition
FR2594691B1 (fr) * 1986-02-24 1990-08-03 Bonne Claude Nouvelles preparations cosmetiques contenant un extrait des fruits de silybum marianum
US4855127A (en) * 1986-07-07 1989-08-08 Dow Corning Corporation Lattice-entrapped composition
JPS63218765A (ja) * 1986-07-07 1988-09-12 ダウ・コ−ニング・コ−ポレ−ション 格子にトラップされた組成物
DE3708451A1 (de) * 1987-03-16 1988-10-06 Henkel Kgaa Zwitterionische polymere und deren verwendung in haarbehandlungsmitteln
FR2697159B1 (fr) * 1992-10-22 1995-01-13 Oreal Composition cosmétique ou dermo-pharmaceutique contenant en association un lauroylméthionate d'un amino acide basique et au moins un polyphénol.
DE4309372C2 (de) * 1993-03-23 1997-08-21 Beiersdorf Ag Kosmetische Desodorantien, enthaltend Gemische aus Wollwachssäuren oder Wollwachssäurekomponenten und Fettsäurepartialglyceriden unverzweigter Fettsäuren
DE4333238A1 (de) * 1993-09-30 1995-04-06 Basf Ag Pyrrolidongruppenhaltige Polyester und Polyamide
US6884842B2 (en) * 1997-10-14 2005-04-26 Alnis Biosciences, Inc. Molecular compounds having complementary surfaces to targets
SG77209A1 (en) * 1997-12-16 2000-12-19 Givaudan Roure Int Polymer
EP0925776A3 (en) * 1997-12-16 2001-08-29 Givaudan SA Polymer with binding capacity for organoleptic substances
NO20002309L (no) * 1999-05-12 2000-11-13 Hoffmann La Roche Fotostabile kosmetiske lysavskjermende sammensetninger
DE60210737T2 (de) * 2002-01-04 2007-01-18 L'oreal S.A. Ein Silikon-Copolymer und entweder ein Polymer aus einem ethylenisch ungesättigten Monomer mit Sulfongruppen oder ein organisches Pulver enthaltende Zusammensetzung; deren Verwendungen, insbesondere in der Kosmetik
CA2488981C (en) * 2003-12-15 2008-06-17 Rohm And Haas Company Oil absorbing composition and process
FR2867070B1 (fr) * 2004-03-04 2009-07-10 Oreal Gel autobronzant transparent contenant un polymere d'acide acrylamido 2-methyl propane sulfonique hydrosoluble ou hydrodispersible
US9308397B2 (en) * 2004-04-30 2016-04-12 The Procter & Gamble Company Long-wearing cosmetic compositions
CN1252099C (zh) * 2004-06-29 2006-04-19 武汉大学 甲基丙烯酸—乙二醇二甲基丙烯酸酯聚合物的用途
GB2418428A (en) * 2004-08-27 2006-03-29 Univ Cranfield Design and use of imprinted polymers, with specific affinity affecting controlled release of chemicals
JP4879554B2 (ja) * 2005-10-21 2012-02-22 株式会社メニコン ポストインプリント可能なヒドロゲル材料の製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008034764A3 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102336871A (zh) * 2010-07-16 2012-02-01 中国科学院过程工程研究所 一种尺寸均一的氯霉素分子印迹聚合物微球及制备方法和应用
CN102336871B (zh) * 2010-07-16 2013-11-06 中国科学院过程工程研究所 一种尺寸均一的氯霉素分子印迹聚合物微球及制备方法和应用

Also Published As

Publication number Publication date
WO2008034764A2 (de) 2008-03-27
KR20090073170A (ko) 2009-07-02
CN101516448A (zh) 2009-08-26
WO2008034764A3 (de) 2008-05-08
RU2499607C2 (ru) 2013-11-27
RU2009114552A (ru) 2010-10-27
JP2010503715A (ja) 2010-02-04
CA2662911A1 (en) 2008-03-27
US20100048737A1 (en) 2010-02-25
US20130085186A1 (en) 2013-04-04
CN101516448B (zh) 2014-07-16

Similar Documents

Publication Publication Date Title
EP2066406A2 (de) Kosmetische zubereitungen auf basis molekular geprägter polymere
EP1915122B1 (de) Copolymere für kosmetische anwendungen
WO2007012574A1 (de) Dermokosmetische zubereitungen
EP1843742A1 (de) Verwendung von wasser-in-wasser-emulsionspolymerisaten als verdicker in kosmetischen zubereitungen
EP1868690A2 (de) Verwendung von polyisobuten enthaltenden copolymerisaten in kosmetischen zusammensetzungen
JP2009503174A (ja) シリコーン基を含有するコポリマー、その製造及び使用
EP2051780A1 (de) Verwendung von kationischen copolymerisaten aus aminhaltigen acrylaten und n-vinylimidazoliumsalzen in haarkosmetischen zubereitungen
EP2175934A2 (de) Kosmetische mittel auf basis von vinylimidazol-polymeren
US20100135917A1 (en) Cosmetically used cross-linked methyl methacrylate-copolymer
WO2006106114A1 (de) Verwendung von polyisobuten enthaltenden copolymerisaten in lichtschutzmitteln
US20130236397A1 (en) Hair setting compositions based on t-butyl acrylate and hydroxyalkyl methacrylate
WO2007110383A1 (de) Verkapselung lipophiler wirkstoffe
DE102004051647A1 (de) Kosmetische Zubereitungen enthaltend Ethylmethacrylat-Copolymere
EP1915124B1 (de) Festigerpolymere auf basis von polyesteracrylaten
WO2006106113A2 (de) Verwendung von polyisobuten enthaltenden copolymerisaten in shampoos und haarpflegemitteln

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17P Request for examination filed

Effective date: 20090420

R17D Deferred search report published (corrected)

Effective date: 20080508

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20090924

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160301